,drug_name,section_name,gpt_output
0,IMPAVIDO,adverse reactions,"nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, elevated creatinine, death, Stevens-Johnson syndrome, melena, thrombocytopenia, arthritis, skin rash, CTCAE Grade 4 diarrhea, CTCAE Grade 4 hyperbilirubinemia, asthenia, motion sickness, malaise, pyrexia, lymphangitis, anemia, lymphadenopathy, abdominal distension, constipation, dysphagia, flatulence, fatigue, abscess, cellulitis, ecthyma, paresthesia, testicular pain, testicular swelling, urticaria, rash, pyoderma, agranulocytosis, generalized edema, peripheral edema, jaundice, seizure, scrotal pain, decreased ejaculate volume, absent ejaculation, epistaxis."
1,IMPAVIDO,boxed warnings,"EMBRYO-FETAL TOXICITY, fetal harm, fetal death, teratogenicity, death"
2,IMPAVIDO,warnings and precautions,"Embryo-Fetal Toxicity, Reproductive effects, Renal Effects, Hepatic Effects, Gastrointestinal Effects, Thrombocytopenia, Absorption of Oral Contraceptives, Stevens-Johnson syndrome, fetal harm, teratogenicity, death, testicular atrophy, impaired fertility, serum creatinine elevation, transaminases elevation, bilirubin elevation, vomiting, diarrhea, volume depletion, scrotal pain, decreased ejaculation, absent ejaculation, follicular atresia, diestrus, reduced viable sperm counts, elevations of serum creatinine, elevations in liver transaminases, ALT elevation, AST elevation, exfoliative rash, bullous rash"
3,LIVALO,adverse reactions,"Rhabdomyolysis, myoglobinuria, acute renal failure, myopathy, myositis, liver enzyme abnormalities, myalgia, back pain, diarrhea, constipation, pain in extremity, arthralgia, headache, influenza, nasopharyngitis, elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, glucose, hypersensitivity reactions, rash, pruritus, urticaria, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, fatigue, malaise, hepatitis, jaundice, hepatic failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, muscle spasms, cognitive impairment, memory loss, forgetfulness, amnesia, memory impairment, confusion, immune-mediated necrotizing myopathy, death"
4,LIVALO,warnings and precautions,"myopathy, rhabdomyolysis, acute renal failure, myoglobinuria, liver enzyme abnormalities, persistent elevations in hepatic transaminases, immune-mediated necrotizing myopathy (IMNM), proximal muscle weakness, elevated serum creatine kinase, liver injury, hyperbilirubinemia, jaundice, hepatic failure, increases in HbA1c, increases in fasting serum glucose levels, death"
5,XENAZINE,adverse reactions,"Depression, suicidality, akathisia, restlessness, agitation, parkinsonism, dysphagia, sedation, somnolence, fatigue, insomnia, anxiety, nausea, irritability, decreased appetite, obsessive reaction, balance difficulty, bradykinesia, dizziness, dysarthria, unsteady gait, headache, vomiting, fall, laceration (head), ecchymosis, upper respiratory tract infection, shortness of breath, bronchitis, dysuria, diarrhea, tremor, confusion, worsening aggression, pneumonia, hyperhidrosis, skin rash"
6,XENAZINE,boxed warnings,"depression, suicidal thoughts, suicidality, worsening of depression, unusual changes in behavior, prior suicide attempts, suicide ideation"
7,XENAZINE,warnings and precautions,"worsening mood, cognition, rigidity, functional capacity, strong CYP2D6 inhibitor, Neuroleptic Malignant Syndrome (NMS), Restlessness, agitation, akathisia, parkinsonism, Dysphagia, aspiration pneumonia, Sedation/Somnolence, QTc prolongation, extrapyramidal disorders, depression, cognitive decline, suicidality, suicide, suicidal ideation, Laboratory Tests, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, tachycardia, diaphoresis, cardiac dysrhythmia, elevated creatinine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, bradykinesia, hypertonia, esophageal dysmotility, torsade de pointes-type ventricular tachycardia, Hypotension, Orthostatic Hypotension, postural dizziness, syncope, Hyperprolactinemia, amenorrhea, galactorrhea, gynecomastia, impotence, low levels of estrogen, increased risk of osteoporosis, Tardive Dyskinesia (TD), involuntary dyskinetic movements, vacuous chewing, dopamine receptor blockade, dopamine receptor supersensitivity, melanin-containing tissues toxicity, long-term ophthalmologic effects, death"
8,LINZESS,adverse reactions,"diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, fecal incontinence, dehydration, gastroesophageal reflux disease, vomiting, fatigue, upper respiratory tract infection, sinusitis, dyspepsia, rectal hemorrhage, hematochezia, melena, allergic reactions, urticaria, hives"
9,LINZESS,boxed warnings,"deaths, dehydration, death"
10,LINZESS,warnings and precautions,"severe diarrhea, diarrhea, mortality, dehydration, death"
11,OPSUMIT,adverse reactions,"Embryo-fetal toxicity, hepatotoxicity, decrease in hemoglobin, anemia, nasopharyngitis, pharyngitis, bronchitis, headache, influenza, urinary tract infection, hypersensitivity reactions, angioedema, pruritus, rash, nasal congestion"
12,OPSUMIT,boxed warnings,"embryo-fetal toxicity, fetal harm"
13,OPSUMIT,warnings and precautions,"hepatotoxicity, liver failure, baseline liver enzymes elevation, decreases in hemoglobin, pulmonary edema, pulmonary veno-occlusive disease, decreases in sperm count, embryo-fetal toxicity, elevations of aminotransferases, elevated aminotransferases, hepatic adverse events, hepatic injury, nausea, vomiting, right upper quadrant pain, fatigue, anorexia, jaundice, dark urine, fever, itching, bilirubin increase, hemoglobin concentration decrease, hematocrit decrease, severe anemia, spermatogenesis adverse effects, fertility effects"
14,ASCLERA,adverse reactions,"mild local reactions, injection site reactions, injection site haematoma, injection site irritation, injection site discoloration, injection site pain, injection site pruritus, injection site warmth, neovascularisation, injection site thrombosis, anaphylactic shock, angioedema, urticaria generalized, asthma, cerebrovascular accident, migraine, paresthesia, loss of consciousness, confusional state, dizziness, cardiac arrest, palpitations, deep vein thrombosis, pulmonary embolism, syncope vasovagal, circulatory collapse, vasculitis, dyspnea, skin hyperpigmentation, dermatitis allergic, hypertrichosis, injection site necrosis, pyrexia, hot flush, nerve injury, death"
15,ASCLERA,warnings and precautions,"anaphylaxis, severe allergic reactions, fatal reactions, tissue necrosis, extravasation, severe necrosis, ischemia, gangrene, inadvertent perivascular injection, pain, death"
16,KYNAMRO,adverse reactions,"hepatotoxicity, injection site reactions, flu-like symptoms, nausea, headache, elevations in serum transaminases, ALT increased, alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, angina pectoris, palpitations, vomiting, abdominal pain, fatigue, influenza like illness, pyrexia, chills, edema peripheral, hepatic steatosis, hepatic enzyme increased, pain in extremity, musculoskeletal pain, insomnia, hypertension, proteinuria, hypersensitivity reaction, angioedema, glomerular nephritis, thrombocytopenia, idiopathic thrombocytopenic purpura"
17,KYNAMRO,boxed warnings,"hepatotoxicity, elevations in transaminases, elevation in alanine aminotransferase (ALT) >= 3x upper limit of normal (ULN), hepatic fat increase, hepatic steatosis, steatohepatitis, cirrhosis, clinically significant liver toxicity"
18,KYNAMRO,warnings and precautions,"erythema, pain, tenderness, pruritus, local swelling, flu-like symptoms, influenza-like illness, pyrexia, chills, myalgia, arthralgia, malaise, fatigue, hepatotoxicity, elevations in transaminases, hepatic steatosis, steatohepatitis, cirrhosis, elevation of transaminases, alanine aminotransferase elevation, aspartate aminotransferase elevation, nausea, vomiting, abdominal pain, fever, jaundice, lethargy"
19,XARELTO,adverse reactions,"Increased risk of stroke, Bleeding risk, Spinal/epidural hematoma, Bleeding, Hemorrhage, Major bleeding, Bleeding into a critical organ, Fatal bleeding, Gastrointestinal bleeding, Intracranial bleeding, Non-fatal critical organ bleeding, Non-fatal non-critical organ bleeding, Decrease in Hb >= 2g/dL, Transfusion of >=2 units of whole blood or packed red blood cells, Clinically relevant non-major bleeding, Any bleeding, Menorrhagia, Extra-surgical site bleeding requiring transfusion of >2 units of whole blood or packed cells, Bleeding that required re-operation, Abdominal pain upper, Dyspepsia, Toothache, Fatigue, Sinusitis, Urinary tract infection, Back pain, Osteoarthritis, Oropharyngeal pain, Wound secretion, Pain in extremity, Muscle spasm, Syncope, Pruritus, Blister, Pulmonary hemorrhage, Pulmonary hemorrhage with bronchiectasis, Agranulocytosis, Thrombocytopenia, Retroperitoneal hemorrhage, Jaundice, Cholestasis, Hepatitis, Hepatocellular injury, Hypersensitivity, Anaphylactic reaction, Anaphylactic shock, Angioedema, Cerebral hemorrhage, Subdural hematoma, Epidural hematoma, Hemiparesis, Stevens-Johnson syndrome, death"
20,XARELTO,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment"
21,XARELTO,warnings and precautions,"bleeding, fatal bleeding, blood loss, obstetric hemorrhage, emergent delivery, thrombotic events, stroke, pathological bleeding, active pathological hemorrhage, hemostasis impairment, epidural hematoma, spinal hematoma, paralysis, neurological impairment, midline back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, acute renal failure, hepatic impairment, coagulopathy, pregnancy-related hemorrhage, fetal distress, death"
22,CAPRELSA,adverse reactions,"QT Prolongation, Torsades de Pointes, Skin Reactions, Stevens-Johnson Syndrome, Interstitial Lung Disease, Ischemic Cerebrovascular Events, Hemorrhage, Heart Failure, Diarrhea, Hypothyroidism, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Embryofetal Toxicity, colitis, rash, acneiform dermatitis, nausea, headache, upper respiratory tract infections, decreased appetite, abdominal pain, asthenia, fatigue, pyrexia, elevated creatinine, Vomiting, Dyspepsia, Dry Mouth, Photosensitivity Reaction, Pruritus, Nail abnormalities, Alopecia, Hypertensive Crisis, Accelerated Hypertension, Headache, Dysgeusia, Fatigue, Upper Respiratory Tract Infections, Decreased Appetite, Hypocalcemia, ECG QT Prolonged, Corneal Abnormalities, Blurred Vision, Proteinuria, Depression, Muscle Spasms, pancreatitis, intestinal perforation, bleeding events, Hypocalcemia, ALT Increased, Hypoglycemia, Creatinine Increased, Hypomagnesemia, Neutropenia, Thrombocytopenia"
23,CAPRELSA,boxed warnings,"QT prolongation, Torsades de Pointes, sudden death, hypocalcemia, hypokalemia, hypomagnesemia, long QT syndrome, death"
24,CAPRELSA,warnings and precautions,"Prolonged QT Interval, Torsades de pointes, sudden death, Severe skin reactions, Stevens-Johnson syndrome, death, Interstitial lung disease (ILD), fatalities, Ischemic cerebrovascular events, hemorrhage, heart failure, diarrhea, hypertension, reversible posterior leukoencephalopathy syndrome, Embryofetal toxicity, photosensitivity reactions, pneumonitis, hypothyroidism, hypertensive crisis, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), ventricular tachycardia, hemoptysis, seizures, headache, visual disturbances, confusion, altered mental function, embryotoxic, fetotoxic, teratogenic, adverse effects on female fertility, embryofetal development, postnatal development of pups"
25,KADCYLA,adverse reactions,"Hepatotoxicity, Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Pulmonary Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Hemorrhage, Thrombocytopenia, Neurotoxicity, Fatigue, Nausea, Musculoskeletal Pain, Headache, Increased Transaminases, Constipation, Epistaxis, Neutropenia, Anemia, Hypokalemia, Peripheral Neuropathy, Asthenia, Nodular Regenerative Hyperplasia, Portal Hypertension, Drug Hypersensitivity, Infusion-Related Reaction, Urinary Tract Infection, Blood Alkaline Phosphatase Increased, Dyspepsia, Stomatitis, Dry Mouth, Abdominal Pain, Vomiting, Diarrhea, Peripheral Edema, Chills, Pyrexia, Lacrimation Increased, Dry Eye, Vision Blurred, Conjunctivitis, Myalgia, Arthralgia, Dysgeusia, Dizziness, Insomnia, Pneumonitis, Dyspnea, Cough, Pruritus, Rash, Hemorrhage, Hypertension, Hepatic Failure, Immunogenicity, Anti-Therapeutic Antibody (ATA) Responses, Death"
26,KADCYLA,boxed warnings,"hepatotoxicity, liver failure, death, cardiac toxicity, reductions in left ventricular ejection fraction (LVEF), embryo-fetal death, birth defects, fetal harm"
27,KADCYLA,warnings and precautions,"pulmonary toxicity, interstitial lung disease, pneumonitis, infusion-related reactions, hypersensitivity reactions, hemorrhage, thrombocytopenia, neurotoxicity, hepatotoxicity, severe drug-induced liver injury, hepatic encephalopathy, nodular regenerative hyperplasia, left ventricular dysfunction, embryo-fetal toxicity, oligohydramnios, pulmonary hypoplasia, skeletal abnormalities, neonatal death, acute respiratory distress syndrome, dyspnea, cough, fatigue, pulmonary infiltrates, flushing, chills, pyrexia, hypotension, wheezing, bronchospasm, tachycardia, central nervous system hemorrhage, respiratory hemorrhage, gastrointestinal hemorrhage, decreased platelet count, peripheral neuropathy, extravasation, erythema, tenderness, skin irritation, pain, swelling at the infusion site, death"
28,RELISTOR,adverse reactions,"Gastrointestinal perforation, Severe diarrhea, Persistent diarrhea, Opioid withdrawal, Abdominal pain, Nausea, Diarrhea, Hyperhidrosis, Hot flush, Tremor, Chills, Flatulence, Dizziness, Vomiting, Feeling of body temperature change, Piloerection, Myocardial infarction, Stroke, Cardiac arrest, Sudden death, Cramping, Diaphoresis, Flushing, Malaise, Pain, Death"
29,RELISTOR,warnings and precautions,"Gastrointestinal perforation, severe abdominal pain, worsening abdominal pain, severe diarrhea, persistent diarrhea, opioid withdrawal, hyperhidrosis, chills, diarrhea, abdominal pain, anxiety, yawning"
30,JUXTAPID,adverse reactions,"hepatotoxicity, reduced absorption of fat-soluble vitamins, reduced serum fatty acids, gastrointestinal adverse reactions, diarrhea, nausea, vomiting, dyspepsia, abdominal pain, gastroenteritis, weight loss, headache, difficulty controlling INR on warfarin, abdominal discomfort, abdominal distension, constipation, flatulence, increased ALT, chest pain, influenza, nasopharyngitis, fatigue, gastroesophageal reflux disease, defecation urgency, rectal tenesmus, decreased weight, fever, back pain, dizziness, pharyngolaryngeal pain, nasal congestion, angina pectoris, palpitations, hepatotoxicity, transaminase elevations, hepatic steatosis"
31,JUXTAPID,boxed warnings,"hepatotoxicity, elevations in transaminases, elevation in alanine aminotransferase (ALT), elevation in aspartate aminotransferase (AST), clinically meaningful elevations of total bilirubin, international normalized ratio (INR) elevations, alkaline phosphatase elevations, hepatic fat increase, hepatic steatosis, steatohepatitis, cirrhosis, liver toxicity, clinically significant liver toxicity"
32,JUXTAPID,warnings and precautions,"Embryo-Fetal Toxicity, Gastrointestinal adverse reactions, Risk of Hepatotoxicity, Elevation of Transaminases, Hepatic Steatosis, Reduced Absorption of Fat-Soluble Vitamins and Serum Fatty Acids, Risk of Myopathy, Supratherapeutic or Subtherapeutic Anticoagulation, Risk of Malabsorption, diarrhea, nausea, dyspepsia, vomiting, abdominal pain, abdominal discomfort, abdominal distension, constipation, flatulence, elevations in bilirubin, jaundice, lethargy, flu-like symptoms, steatohepatitis, cirrhosis, liver injury, liver disease, liver failure, hepatotoxicity, teratogenicity, myopathy, rhabdomyolysis, malabsorption"
33,SAVELLA,adverse reactions,"nausea, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, vomiting, palpitations, heart rate increased, dry mouth, hypertension, tachycardia, vision blurred, abdominal pain, chest pain, chills, chest discomfort, upper respiratory tract infection, blood pressure increased, decreased appetite, migraine, paresthesia, tremor, hypoesthesia, tension headache, anxiety, dyspnea, rash, pruritus, flushing, weight loss, weight gain, dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, libido decreased, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, urine flow decreased, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension, fatigue, peripheral edema, irritability, pyrexia, urinary tract infection, cystitis, contusion, fall, hypercholesterolemia, somnolence, dysgeusia, depression, stress, night sweats, leukopenia, neutropenia, thrombocytopenia, supraventricular tachycardia, accommodation disorder, hyperprolactinemia, hepatitis, anorexia, hyponatremia, rhabdomyolysis, convulsions, loss of consciousness, Parkinsonism, aggression, anger, delirium, hallucination, homicidal ideation, acute renal failure, galactorrhea, erythema multiforme, Stevens Johnson syndrome, hypertensive crisis"
34,SAVELLA,boxed warnings,"suicidality, suicidal thinking, suicidal behavior, clinical worsening, unusual changes in behavior"
35,SAVELLA,warnings and precautions,"suicidality, suicide risk, worsening of depressive symptoms, Serotonin Syndrome, elevated blood pressure, heart rate elevations, Seizures, Hepatotoxicity, ALT elevations, AST elevations, fulminant hepatitis, Withdrawal symptoms, Abnormal Bleeding, genitourinary adverse events, dysuria, urinary retention, testicular pain, ejaculation disorders, Angle Closure Glaucoma, elevated transaminases, hyponatremia, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, anxiety, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, emotional lability, headache, lethargy, tinnitus, seizures, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, respiratory arrest, ecchymoses, hematomas, epistaxis, petechiae, hemorrhages, activation of mania, hypomania, angle closure attack, liver disease, chronic liver disease, alcohol use"
36,SAMSCA,adverse reactions,"thirst, dry mouth, asthenia, constipation, pollakiuria, polyuria, hyperglycemia, death, pyrexia, anorexia, nausea, gastrointestinal bleeding, disseminated intravascular coagulation, intracardiac thrombus, ventricular fibrillation, prothrombin time prolonged, ischemic colitis, diabetic ketoacidosis, rhabdomyolysis, cerebrovascular accident, urethral hemorrhage, vaginal hemorrhage, pulmonary embolism, respiratory failure, deep vein thrombosis, osmotic demyelination syndrome, hypernatremia, hypersensitivity reactions, anaphylactic shock, rash generalized"
37,SAMSCA,boxed warnings,"hyponatremia, osmotic demyelination, dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, death"
38,SAMSCA,warnings and precautions,"Liver injury, hepatic injury, dehydration, hypovolemia, osmotic demyelination syndrome, dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, death, serious liver injury, fatal liver injury, increased ALT, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, hyperkalemia"
39,JETREA,adverse reactions,"Decreased Vision, Intravitreal Injection Procedure Associated Effects, Potential for Lens Subluxation, Retinal Breaks, vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema, macular edema, increased intraocular pressure, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, dyschromatopsia"
40,JETREA,warnings and precautions,"decreases in vision, progression of the condition with traction, surgical intervention, intraocular inflammation, intraocular infection, intraocular hemorrhage, increased intraocular pressure (IOP), lens subluxation, retinal detachment, retinal tear, dyschromatopsia, yellowish vision, electroretinographic (ERG) changes, a-wave amplitude decrease, b-wave amplitude decrease"
41,OPDIVO,adverse reactions,"Immune-Mediated Pneumonitis, Immune-Mediated Colitis, Immune-Mediated Hepatitis, Immune-Mediated Nephritis, Renal Dysfunction, Immune-Mediated Hypothyroidism, Hyperthyroidism, Other Immune-Mediated Adverse Reactions, Rash, Fatigue, Dyspnea, Musculoskeletal Pain, Decreased Appetite, Cough, Nausea, Constipation, Abdominal Pain, Hyponatremia, Increased Aspartate Aminotransferase, Increased Lipase, Pruritus, Upper Respiratory Tract Infection, Peripheral Edema, Ventricular Arrhythmia, Iridocyclitis, Infusion-Related Reactions, Increased Amylase, Dizziness, Peripheral Neuropathy, Sensory Neuropathy, Exfoliative Dermatitis, Erythema Multiforme, Vitiligo, Psoriasis, Increased Alkaline Phosphatase, Hyperkalemia, Increased ALT, Asthenia, Pyrexia, Chest Pain, Pain, Arthralgia, Vomiting, Diarrhea, Decreased Weight, Pneumonia, Stomatitis, Peripheral Neuropathy, Bronchitis, Upper Respiratory Tract Infection, Hyponatremia, Increased Creatinine, Hypercalcemia, Hypokalemia, Hypomagnesemia, Hypocalcemia, Hyperkalemia, Increased AST, Increased Alkaline Phosphatase, Increased ALT, Lymphopenia, Anemia, Thrombocytopenia"
42,OPDIVO,warnings and precautions,"immune-mediated pneumonitis, pneumonitis, interstitial lung disease, immune-mediated colitis, colitis, diarrhea, immune-mediated hepatitis, hepatitis, liver test abnormalities, AST elevation, alkaline phosphatase elevation, ALT elevation, total bilirubin elevation, immune-mediated nephritis, renal dysfunction, elevated creatinine, immune-mediated hypothyroidism, hypothyroidism, immune-mediated hyperthyroidism, hyperthyroidism, adrenal insufficiency, uveitis, pancreatitis, facial nerve paresis, abducens nerve paresis, demyelination, autoimmune neuropathy, motor dysfunction, vasculitis, hypophysitis, diabetic ketoacidosis, hypopituitarism, Guillain-Barre syndrome, myasthenic syndrome, embryofetal toxicity, fetal harm, abortion, premature infant death, death"
43,VICTOZA,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Renal Impairment, Hypersensitivity Reactions, Headache, Nausea, Diarrhea, Anti-liraglutide antibody formation, Immunogenicity-related events, Urticaria, Injection site reactions, Papillary thyroid carcinoma, Bilirubin elevation, Calcitonin elevation, Increased heart rate, Medullary thyroid carcinoma, Dehydration, Increased serum creatinine, Acute renal failure, Worsening of chronic renal failure, Angioedema, Anaphylactic reactions, Allergic reactions, Rash, Pruritus, Acute pancreatitis, Hemorrhagic pancreatitis, Necrotizing pancreatitis, Death (related to pancreatitis), Vomiting, Dyspepsia, Constipation, Upper respiratory tract infections, Malignant neoplasms, Colon cancer, Prostate cancer, Nasopharyngeal cancer."
44,VICTOZA,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
45,VICTOZA,warnings and precautions,"Thyroid C-cell tumors, Pancreatitis, fatal pancreatitis, non-fatal hemorrhagic pancreatitis, necrotizing pancreatitis, Serious Hypoglycemia, Renal Impairment, acute renal failure, worsening of chronic renal failure, Hypersensitivity, serious hypersensitivity reactions, anaphylactic reactions, angioedema, death"
46,EFFIENT,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, death, thrombotic thrombocytopenic purpura, symptomatic intracranial hemorrhage, requiring inotropes, requiring surgical intervention, requiring transfusion, epistaxis, gastrointestinal hemorrhage, hemoptysis, subcutaneous hematoma, post-procedural hemorrhage, retroperitoneal hemorrhage, pericardial effusion/hemorrhage/tamponade, retinal hemorrhage, severe thrombocytopenia, anemia, abnormal hepatic function, allergic reactions, angioedema, hypertension, hypercholesterolemia, hyperlipidemia, headache, back pain, dyspnea, nausea, dizziness, cough, hypotension, fatigue, non-cardiac chest pain, atrial fibrillation, bradycardia, leukopenia, rash, pyrexia, peripheral edema, pain in extremity, diarrhea, thrombocytopenia, hypersensitivity reactions, anaphylaxis."
47,EFFIENT,boxed warnings,"significant bleeding, fatal bleeding, death, active pathological bleeding, transient ischemic attack, stroke, intracranial bleeding, hypotensive, cardiovascular events"
48,EFFIENT,warnings and precautions,"CABG-related bleeding, stent thrombosis, myocardial infarction, death, thrombotic thrombocytopenic purpura (TTP), hypersensitivity, angioedema, bleeding, TIMI Major bleeding, TIMI Minor bleeding, intracranial hemorrhage, hypotension, active bleeding, transient ischemic attack (TIA), stroke, gastrointestinal (GI) bleeding, active peptic ulcer disease, severe hepatic impairment, moderate to severe renal impairment, microangiopathic hemolytic anemia, neurological findings, renal dysfunction, fever."
49,ENTYVIO,adverse reactions,"Infusion-Related Reactions, Hypersensitivity Reactions, Infections, Progressive Multifocal Leukoencephalopathy, Liver Injury, Nasopharyngitis, Headache, Arthralgia, Nausea, Pyrexia, Upper Respiratory Tract Infection, Fatigue, Cough, Bronchitis, Influenza, Back Pain, Rash, Pruritus, Sinusitis, Oropharyngeal Pain, Pain in Extremities, Anaphylaxis, Dyspnea, Bronchospasm, Urticaria, Flushing, Increased Blood Pressure, Increased Heart Rate, Dizziness, Vomiting, Urinary Tract Infection, Anal Abscess, Sepsis, Tuberculosis, Salmonella Sepsis, Listeria Meningitis, Giardiasis, Cytomegaloviral Colitis, Hepatitis, Malignancies, Colon Cancer, Transitional Cell Carcinoma, Breast Cancer, Carcinoid Tumor, Squamous Cell Carcinoma, B-cell Lymphoma, Malignant Hepatic Neoplasm, Malignant Lung Neoplasm, Malignant Melanoma, Lung Cancer, Renal Cancer, Death"
50,ENTYVIO,warnings and precautions,"Hypersensitivity Reactions, anaphylaxis, serious allergic reactions, Infections, severe infections, Progressive Multifocal Leukoencephalopathy (PML), death, dyspnea, bronchospasm, urticaria, flushing, rash, increased blood pressure, increased heart rate, upper respiratory tract infection, nasopharyngitis, anal abscess, sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis, neurological signs or symptoms, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory changes, orientation changes, confusion, personality changes, severe disability, Liver Injury, elevations of transaminase, elevated bilirubin, jaundice, significant liver injury."
51,ADEMPAS,adverse reactions,"Embryo-Fetal Toxicity, Hypotension, Bleeding, Headache, Dyspepsia, Gastritis, Dizziness, Nausea, Diarrhea, Vomiting, Anemia, Gastroesophageal Reflux Disease, Constipation, Palpitations, Nasal Congestion, Epistaxis, Dysphagia, Abdominal Distension, Peripheral Edema"
52,ADEMPAS,boxed warnings,"embryo-fetal toxicity, fetal harm"
53,ADEMPAS,warnings and precautions,"symptomatic hypotension, bleeding, pulmonary edema, fetal harm, hypotension, ischemia, hypovolemia, severe left ventricular outflow obstruction, resting hypotension, autonomic dysfunction, serious bleeding, serious hemoptysis, vaginal hemorrhage, catheter site hemorrhage, subdural hematoma, hematemesis, intra-abdominal hemorrhage, death"
54,MOVANTIK,adverse reactions,"Gastrointestinal perforation, Opioid withdrawal, Abdominal pain, Diarrhea, Nausea, Flatulence, Vomiting, Headache, Hyperhidrosis, Chills, Anxiety, Irritability, Yawning"
55,MOVANTIK,warnings and precautions,"Gastrointestinal perforation, severe abdominal pain, persistent abdominal pain, worsening abdominal pain, opioid withdrawal, hyperhidrosis, chills, diarrhea, abdominal pain, anxiety, irritability, yawning, gastrointestinal adverse reactions, reduced analgesia."
56,STIVARGA,adverse reactions,"hepatotoxicity, hemorrhage, dermatological toxicity, hypertension, cardiac ischemia, infarction, reversible posterior leukoencephalopathy syndrome (RPLS), gastrointestinal perforation, fistula, asthenia, fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite, food intake, mucositis, dysphonia, infection, pain (not otherwise specified), decreased weight, gastrointestinal pain, abdominal pain, rash, fever, nausea, anemia, thrombocytopenia, neutropenia, lymphopenia, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, hyperbilirubinemia, increased AST, increased ALT, proteinuria, increased INR, increased lipase, increased amylase, alopecia, hypothyroidism, headache, weight loss, musculoskeletal stiffness, hypersensitivity reaction, death"
57,STIVARGA,boxed warnings,"hepatotoxicity, severe hepatotoxicity, fatal hepatotoxicity, elevated liver function tests, hepatocellular necrosis, death"
58,STIVARGA,warnings and precautions,"hemorrhage, severe hemorrhage, life-threatening hemorrhage, fatal hemorrhage, dermatological toxicity, skin toxicity, subcutaneous tissue toxicity, hand-foot skin reaction (HFSR), palmar-plantar erythrodysesthesia (PPE), severe rash, erythema multiforme, Stevens Johnson Syndrome, toxic epidermal necrolysis, hypertension, hypertensive crisis, cardiac ischemia, myocardial infarction, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), gastrointestinal perforation, gastrointestinal fistula, wound healing complications, wound dehiscence, embryofetal toxicity, fetal harm, embryolethal, teratogenic, cardiovascular malformations, genitourinary malformations, skeletal malformations, hepatotoxicity, severe drug-induced liver injury, fatal hepatic failure, hepatocyte necrosis, lymphocyte infiltration, death"
59,ANORO,adverse reactions,"asthma-related death, paradoxical bronchospasm, cardiovascular effects, worsening of narrow-angle glaucoma, worsening of urinary retention, pharyngitis, sinusitis, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, chest pain, productive cough, dry mouth, dyspepsia, abdominal pain, gastroesophageal reflux disease, vomiting, musculoskeletal chest pain, chest discomfort, asthenia, atrial fibrillation, ventricular extrasystoles, supraventricular extrasystoles, myocardial infarction, pruritus, rash, conjunctivitis, headache, back pain, cough, urinary tract infection, arthralgia, nausea, vertigo, pleuritic pain, viral respiratory tract infection, toothache, diabetes mellitus, death"
60,ANORO,boxed warnings,"asthma-related death, death"
61,ANORO,warnings and precautions,"asthma-related death, death, acutely deteriorating COPD, acute symptoms, overdose, paradoxical bronchospasm, cardiovascular disorders, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, narrow-angle glaucoma, urinary retention, hypokalemia, hyperglycemia, deteriorating disease, excessive use of inhaled sympathomimetic drugs, cardiovascular effects, fatalities, drug interactions, hypersensitivity reactions, anaphylactic reactions, increases in pulse rate, systolic blood pressure increase, diastolic blood pressure increase, electrocardiographic changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, coronary insufficiency, cardiac arrhythmias, hypertension, aggravate preexisting diabetes, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes from conjunctival congestion, corneal edema, difficulty passing urine, painful urination, prostatic hyperplasia, bladder-neck obstruction, significant hypokalemia, transient hyperglycemia"
62,VIMPAT,adverse reactions,"Suicidal Behavior and Ideation, Dizziness, Ataxia, Cardiac Rhythm and Conduction Abnormalities, Syncope, Multiorgan Hypersensitivity Reactions, Diplopia, Headache, Nausea, Insomnia, Somnolence, Fatigue, Vomiting, Vertigo, Blurred Vision, Diarrhea, Gait disturbance, Asthenia, Contusion, Skin laceration, Tremor, Nystagmus, Balance disorder, Memory impairment, Depression, Pruritus, Neutropenia, Anemia, Palpitations, Tinnitus, Constipation, Dyspepsia, Dry mouth, Oral hypoaesthesia, Irritability, Pyrexia, Feeling drunk, Fall, Muscle spasms, Paresthesia, Cognitive disorder, Hypoaesthesia, Dysarthria, Disturbance in attention, Cerebellar syndrome, Confusional state, Mood altered, Depressed mood, Injection site pain, Injection site discomfort, Injection site irritation, Injection site erythema, Profound bradycardia, Agranulocytosis, Aggression, Agitation, Hallucination, Psychotic disorder, Angioedema, Rash, Urticaria, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Abnormalities in liver function tests, Hepatitis, Nephritis, Neutropenia, Anemia, Palpitations, Tinnitus, Constipation, Dyspepsia, Dry mouth, Oral hypoaesthesia, Irritability, Pyrexia, Feeling drunk, Fall, Muscle spasms, Paresthesia, Cognitive disorder, Hypoaesthesia, Dysarthria, Disturbance in attention, Cerebellar syndrome, Confusional state, Mood altered, Depressed mood, Pruritus, Hyperhidrosis."
63,VIMPAT,warnings and precautions,"suicidal behavior, suicidal ideation, suicidal thoughts, depression, mood changes, behavior changes, self-harm, dizziness, ataxia, cardiac rhythm abnormalities, conduction abnormalities, ECG changes, PR interval prolongation, first-degree atrioventricular block, second-degree atrioventricular block, complete AV block, bradycardia, myocardial ischemia, heart failure, structural heart disease, atrial fibrillation, atrial flutter, syncope, loss of consciousness, orthostatic blood pressure changes, tachycardia, seizure frequency increase, multiorgan hypersensitivity reactions, symptomatic hepatitis, nephritis, rash, elevated liver enzymes, myocarditis, fever, eosinophilia, lymphadenopathy, phenylketonuria, death"
64,BANZEL,adverse reactions,"Suicidal Behavior and Ideation, Central Nervous System Reactions, QT Shortening, Multi-Organ Hypersensitivity, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Leukopenia, headache, dizziness, fatigue, somnolence, nausea, vomiting, influenza, nasopharyngitis, decreased appetite, rash, ataxia, diplopia, bronchitis, sinusitis, psychomotor hyperactivity, upper abdominal pain, aggression, ear infection, disturbance in attention, pruritis, tremor, nystagmus, blurred vision, anxiety, constipation, dyspepsia, back pain, gait disturbance, vertigo, convulsion, anemia, lymphadenopathy, neutropenia, iron deficiency anemia, thrombocytopenia, bundle branch block right, atrioventricular block first degree, pollakiuria, urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence, Stevens-Johnson syndrome"
65,BANZEL,warnings and precautions,"new or worsening depression, suicidal thoughts/behavior, unusual changes in mood or behavior, central nervous system reactions, QT interval shortening, multi-organ hypersensitivity reaction, seizure exacerbation, status epilepticus, somnolence, fatigue, coordination abnormalities, dizziness, gait disturbances, ataxia, sudden death, ventricular arrhythmias, ventricular fibrillation, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, leukopenia, death"
66,XELJANZ,adverse reactions,"upper respiratory tract infections, headache, diarrhea, nasopharyngitis, serious infections, pneumonia, cellulitis, herpes zoster, urinary tract infections, tuberculosis, opportunistic infections, malignancies, lymphoma, lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, malignant melanoma, lymphopenia, neutropenia, liver enzyme elevations, drug-induced liver injury, lipid elevations, serum creatinine elevations, anemia, diverticulitis, dehydration, insomnia, paresthesia, dyspnea, cough, sinus congestion, abdominal pain, dyspepsia, vomiting, gastritis, nausea, hepatic steatosis, rash, erythema, pruritus, musculoskeletal pain, arthralgia, tendonitis, joint swelling, non-melanoma skin cancers, pyrexia, fatigue, peripheral edema"
67,XELJANZ,boxed warnings,"serious infections, hospitalization, death, tuberculosis, bacterial infections, invasive fungal infections, viral infections, opportunistic infections, lymphoma, malignancies, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, cryptococcosis, pneumocystosis, active tuberculosis, pulmonary disease, extrapulmonary disease, disseminated disease, localized disease, chronic infection, recurrent infection"
68,XELJANZ,warnings and precautions,"serious infection, localized infections, gastrointestinal perforations, lymphocyte abnormalities, neutropenia, anemia, liver enzyme elevations, lipid elevations, viral reactivation, herpes virus reactivation, herpes zoster, chronic viral hepatitis reactivation, malignancy, lymphoproliferative disorders, non-melanoma skin cancer, tuberculosis, opportunistic infections, bacterial infections, mycobacterial infections, invasive fungal infections, viral infections, pneumonia, cellulitis, urinary tract infection, diverticulitis, tuberculosis, cryptococcosis, esophageal candidiasis, pneumocystosis, multidermatomal herpes zoster, cytomegalovirus, BK virus, histoplasmosis, coccidioidomycosis, listeriosis, Epstein Barr Virus-associated post-transplant lymphoproliferative disorder, death"
69,GATTEX,adverse reactions,"abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection, vomiting, fluid overload, flatulence, hypersensitivity, appetite disorders, sleep disturbances, cough, skin hemorrhage, gastrointestinal stoma complication, malignancy, colorectal polyps, gastrointestinal obstruction, gallbladder disease, biliary disease, pancreatic disease, congestive heart failure, cognition and attention disturbances, immunogenicity, anti-GATTEX antibody, neutralizing antibodies"
70,GATTEX,warnings and precautions,"neoplastic growth, acceleration of neoplastic growth, intestinal malignancy, intestinal obstruction, biliary disease, pancreatic disease, fluid overload, colorectal polyps, small bowel neoplasia, colorectal cancer, small bowel cancer, gallbladder disease, biliary tract disease, cholecystitis, cholangitis, cholelithiasis, pancreatitis, congestive heart failure, altered mental status"
71,XOFIGO,adverse reactions,"Bone Marrow Suppression, nausea, diarrhea, vomiting, peripheral edema, anemia, lymphocytopenia, leukopenia, thrombocytopenia, neutropenia, pancytopenia, renal failure and impairment, dehydration, erythema, pain, edema, secondary malignant neoplasms, osteosarcoma"
72,XOFIGO,warnings and precautions,"Bone Marrow Suppression, hematologic values not recover, compromised bone marrow reserve, life-threatening complications, bone marrow failure, ongoing pancytopenia, deaths due to bone marrow failure, blood transfusions, therapy permanently discontinued due to bone marrow suppression, vascular hemorrhage, myelosuppression, infection-related deaths, serious infections, febrile neutropenia, thrombocytopenia, neutropenia, pancytopenia, leukopenia, neutrophil count nadirs, platelet count nadirs, death"
73,SYNRIBO,adverse reactions,"myelosuppression, bleeding, hyperglycemia, thrombocytopenia, anemia, neutropenia, diarrhea, nausea, fatigue, asthenia, injection site reaction, pyrexia, infection, lymphopenia, pancytopenia, increased alanine aminotransferase, bone marrow failure, febrile neutropenia, constipation, abdominal pain, upper abdominal pain, vomiting, edema peripheral, leukocytosis, arthralgia, pain in extremity, back pain, myalgia, headache, insomnia, cough, epistaxis, alopecia, rash, anorexia, chills, dyspnea, cerebral hemorrhage, multi-organ failure, progression of disease, bone marrow necrosis, hyperosmolar non-ketotic hyperglycemia, elevated transaminases, hemoglobin decreased, leukocytes decreased, neutrophils decreased, platelets decreased, bilirubin increased, creatinine increased, glucose increased, uric acid increased, glucose decreased, tachycardia, palpitations, acute coronary syndrome, angina pectoris, arrhythmia, bradycardia, ventricular extrasystoles, ear pain, ear hemorrhage, tinnitus, cataract, vision blurred, conjunctival hemorrhage, dry eye, lacrimation increased, conjunctivitis, diplopia, eye pain, eyelid edema, stomatitis, mouth ulceration, abdominal distension, dyspepsia, gastroesophageal reflux disease, gingival bleeding, aphthous stomatitis, dry mouth, hemorrhoids, gastritis, gastrointestinal hemorrhage, melena, mouth hemorrhage, oral pain, anal fissure, dysphagia, gingival pain, gingivitis, mucosal inflammation, pain, chest pain, hyperthermia, influenza-like illness, catheter site pain, general edema, malaise, hypersensitivity, contusion, transfusion reaction, decreased appetite, diabetes mellitus, gout, dehydration, bone pain, muscular weakness, muscle spasms, musculoskeletal chest pain, musculoskeletal pain, musculoskeletal stiffness, musculoskeletal discomfort, dizziness, paresthesia, convulsion, hypoesthesia, lethargy, sciatica, burning sensation, dysgeusia, tremor, anxiety, depression, agitation, confusional state, mental status change, dysuria, pharyngolaryngeal pain, nasal congestion, dysphonia, productive cough, rales, rhinorrhea, hemoptysis, sinus congestion, erythema, pruritus, dry skin, petechiae, hyperhidrosis, night sweats, ecchymosis, purpura, skin lesion, skin ulcer, rash erythematous, rash papular, skin exfoliation, skin hyperpigmentation, hematoma, hypertension, hot flush, hypotension, death."
74,SYNRIBO,warnings and precautions,"myelosuppression, thrombocytopenia, neutropenia, anemia, bleeding, hemorrhage, cerebral hemorrhage, gastrointestinal hemorrhage, hyperglycemia, glucose intolerance, hyperosmolar non-ketotic hyperglycemia, embryo-fetal toxicity, fetal harm, death"
75,ICLUSIG,adverse reactions,"Vascular Occlusion, Heart Failure, Hepatotoxicity, Hypertension, Pancreatitis, Neuropathy, Ocular Toxicity, Hemorrhage, Fluid Retention, Cardiac Arrhythmias, Myelosuppression, Arterial ischemia, Abdominal pain, Fatigue, Headache, Dry skin, Constipation, Arthralgia, Nausea, Pyrexia, Thrombocytopenia, Infections, Rash, Diarrhea, Vomiting, Oral mucositis, GI hemorrhage, Febrile neutropenia, Sepsis, Pneumonia, Urinary tract infection, Upper respiratory tract infection, Nasopharyngitis, Cellulitis, Peripheral neuropathy, Dizziness, Pleural effusion, Cough, Dyspnea, Rash and related conditions, Musculoskeletal pain, Myalgia, Pain in extremity, Back pain, Muscle spasms, Bone pain, Fatigue or asthenia, Edema, peripheral, Pain, Chills, Decreased appetite, Weight decreased, Insomnia, Arterial ischemic event, CNS hemorrhage, Gastrointestinal hemorrhage, Cardiac failure, Effusions, Atrial fibrillation, Venous thromboembolism, Anemia, Lymphopenia, Leukopenia, ALT increased, AST increased, Alkaline phosphatase increased, Albumin decreased, Bilirubin increased, Lipase increased, Amylase increased, Glucose increased, Phosphorus decreased, Calcium decreased, Sodium decreased, Glucose decreased, Potassium decreased, Potassium increased, Sodium increased, Bicarbonate decreased, Creatinine increased, Calcium increased, Triglycerides increased"
76,ICLUSIG,boxed warnings,"vascular occlusion, arterial thrombosis, venous thrombosis, myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, urgent revascularization procedures, heart failure, hepatotoxicity, liver failure, death"
77,ICLUSIG,warnings and precautions,"hypertension, high blood pressure, pancreatitis, neuropathy, peripheral neuropathy, cranial neuropathy, ocular toxicity, blindness, blurred vision, macular edema, retinal vein occlusion, retinal hemorrhage, conjunctival irritation, corneal irritation, dry eye, eye pain, cataracts, glaucoma, iritis, iridocyclitis, ulcerative keratitis, hemorrhage, serious bleeding, cerebral hemorrhage, gastrointestinal hemorrhage, fluid retention, brain edema, pericardial effusion, pleural effusion, ascites, peripheral edema, cardiac arrhythmias, bradyarrhythmias, complete heart block, sick sinus syndrome, atrial fibrillation, bradycardia, supraventricular tachyarrhythmias, atrial flutter, supraventricular tachycardia, atrial tachycardia, myelosuppression, thrombocytopenia, neutropenia, anemia, tumor lysis syndrome, hyperuricemia, compromised wound healing, gastrointestinal perforation, fistula, embryo-fetal toxicity, fetal harm, hepatotoxicity, liver failure, death, myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, urgent revascularization procedures, vascular occlusion, arterial occlusion, thrombosis, venous thromboembolism, deep venous thrombosis, pulmonary embolism, superficial thrombophlebitis, retinal vein thrombosis, heart failure, left ventricular dysfunction, fulminant hepatic failure, acute liver failure, mesenteric artery occlusion, peripheral arterial disease, digital necrosis, distal extremity necrosis, amputations, symptomatic hypertension, hypertensive crisis, lipase elevation, paresthesia, hypoesthesia, hyperesthesia, neuropathic pain, weakness, ALT elevation, AST elevation."
78,SABRIL,adverse reactions,"Vision Loss, Magnetic Resonance Imaging (MRI) Abnormalities in Infants, Neurotoxicity, Suicidal Behavior and Ideation, Withdrawal of Antiepileptic Drugs (AEDs), Anemia, Somnolence, Fatigue, Peripheral Neuropathy, Weight Gain, Edema, Nystagmus, Tremor, Vision Blurred, Memory Impairment, Arthralgia, Abnormal Coordination, Confusional State, Upper Respiratory Tract Infection, Aggression, Diplopia, Bronchitis, Ear Infection, Otitis Media Acute, Headache, Dizziness, Convulsion, Nasopharyngitis, Visual Field Defect, Depression, Insomnia, Irritability, Coordination Abnormal, Nausea, Diarrhea, Vomiting, Influenza, Pyrexia, Rash, Tinnitus, Vertigo, Asthenopia, Eye Pain, Constipation, Abdominal Pain Upper, Dyspepsia, Stomach Discomfort, Abdominal Pain, Toothache, Abdominal Distension, Gait Disturbance, Asthenia, Oedema Peripheral, Fever, Chest Pain, Thirst, Malaise, Urinary Tract Infection, Contusion, Joint Sprain, Muscle Strain, Wound Secretion, Increased Appetite, Back Pain, Pain in Extremity, Myalgia, Muscle Twitching, Muscle Spasms, Disturbance in Attention, Sensory Disturbance, Hyporeflexia, Paraesthesia, Lethargy, Hyperreflexia, Hypoaesthesia, Sedation, Status Epilepticus, Dysarthria, Postictal State, Sensory Loss, Anxiety, Depressed Mood, Thinking Abnormal, Abnormal Behaviour, Expressive Language Disorder, Nervousness, Abnormal Dreams, Dysmenorrhoea, Erectile Dysfunction, Pharyngolaryngeal Pain, Cough, Pulmonary Congestion, Sinus Headache, Acne, Psychomotor Hyperactivity, Disorientation, Strabismus, Conjunctivitis, Viral Infection, Pneumonia, Candidiasis, Gastroenteritis Viral, Sinusitis, Croup Infectious, Decreased Appetite, Sedation, Lethargy, Convulsion, Hypotonia, Nasal Congestion, Congenital Cardiac Defects, Congenital External Ear Anomaly, Congenital Hemangioma, Congenital Hydronephrosis, Congenital Male Genital Malformation, Congenital Oral Malformation, Congenital Vesicoureteric Reflux, Dentofacial Anomaly, Dysmorphism, Fetal Anticonvulsant Syndrome, Hamartomas, Hip Dysplasia, Limb Malformation, Limb Reduction Defect, Low Set Ears, Renal Aplasia, Retinitis Pigmentosa, Supernumerary Nipple, Talipes, Deafness, Delayed Puberty, Gastrointestinal Hemorrhage, Esophagitis, Developmental Delay, Facial Edema, Malignant Hyperthermia, Multi-organ Failure, Cholestasis, Dystonia, Encephalopathy, Hypertonia, Muscle Spasticity, Myoclonus, Optic Neuritis, Dyskinesia, Acute Psychosis, Apathy, Delirium, Hypomania, Neonatal Agitation, Psychotic Disorder, Laryngeal Edema, Pulmonary Embolism, Respiratory Failure, Stridor, Angioedema, Maculo-papular Rash, Pruritus, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN)"
79,SABRIL,boxed warnings,"permanent bilateral concentric visual field constriction, vision loss, tunnel vision, decrease in visual acuity, severe vision loss, retinopathy, glaucoma, progressive visual field constriction, worsening vision loss"
80,SABRIL,warnings and precautions,"Permanent vision loss, Abnormal MRI signal changes, Suicidal behavior and ideation, Withdrawal seizures, Anemia, Somnolence, Fatigue, Peripheral neuropathy, Weight gain, Edema"
81,VPRIV,adverse reactions,"hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue, asthenia, pyrexia, bone pain, tachycardia, rash, urticaria, flushing, hypertension, hypotension"
82,VPRIV,warnings and precautions,"hypersensitivity reactions, anaphylaxis, headache, dizziness, hypotension, hypertension, nausea, fatigue, asthenia, pyrexia, body temperature increased, chest discomfort, dyspnea, pruritus"
83,DALIRESP,adverse reactions,"Psychiatric Events Including Suicidality, Weight Decrease, Diarrhea, Nausea, Headache, Back Pain, Influenza, Insomnia, Dizziness, Decreased Appetite, Atrial Fibrillation, Lung Cancer, Prostate Cancer, Acute Pancreatitis, Acute Renal Failure, Abdominal Pain, Dyspepsia, Gastritis, Vomiting, Rhinitis, Sinusitis, Urinary Tract Infection, Muscle Spasms, Tremor, Anxiety, Depression, Hypersensitivity Reactions, Angioedema, Urticaria, Rash"
84,DALIRESP,warnings and precautions,"acute bronchospasm, psychiatric events, suicidality, insomnia, anxiety, depression, suicidal thoughts, mood changes, weight decrease, weight loss, moderate weight loss, severe weight loss, drug interactions, completed suicide, suicide attempts, suicidal ideation, death"
85,SYLVANT,adverse reactions,"severe infections, infusion-related reactions, hypersensitivity, pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, rash generalized, rash maculo-papular, rash popular, rash pruritic, skin hyperpigmentation, eczema, psoriasis, dry skin, lower respiratory tract infection, thrombocytopenia, edema, constipation, hypertriglyceridemia, hypercholesterolemia, oropharyngeal pain, renal impairment, headache, hypotension, abdominal pain, abdominal distension, decreased appetite, dehydration, peripheral edema, diarrhea, pain in extremities, arthralgia, fatigue, anaphylaxis, back pain, chest pain, nausea, vomiting, flushing, erythema, palpitations"
86,SYLVANT,warnings and precautions,"severe infections, infections, live vaccine interference, infusion related reactions, anaphylaxis, mild to moderate infusion reaction, gastrointestinal perforation"
87,LASTACAFT,adverse reactions,"eye irritation, burning and/or stinging on instillation, eye redness, eye pruritus, nasopharyngitis, headache, eye discharge, eye swelling, erythema of eyelid, eyelid edema, hypersensitivity, somnolence"
88,LASTACAFT,warnings and precautions,"eye injury, contamination, contact lens-related irritation, red eye"
89,GAZYVA,adverse reactions,"Hepatitis B reactivation, Progressive multifocal leukoencephalopathy, Infusion reactions, Tumor lysis syndrome, Infections, Neutropenia, Thrombocytopenia, Anemia, Pyrexia, Cough, Nausea, Diarrhea, Leukopenia, Urinary tract infection, Back pain, Nasopharyngitis, Constipation, Lymphopenia, Hypocalcemia, Hyperkalemia, Hyponatremia, AST (SGOT increased), Creatinine increased, ALT (SGPT increased), Hypoalbuminemia, Alkaline phosphatase increased, Hypokalemia, Musculoskeletal disorders, Liver enzyme elevations, Immunogenicity, Worsening of Pre-existing Cardiac Conditions, death"
90,GAZYVA,boxed warnings,"Hepatitis B Virus reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML)"
91,GAZYVA,warnings and precautions,"infusion reactions, tumor lysis syndrome, neutropenia, thrombocytopenia, immunization complications, hepatitis B virus reactivation, fulminant hepatitis, hepatic failure, death, progressive multifocal leukoencephalopathy (PML), hypotension, tachycardia, dyspnea, respiratory symptoms, bronchospasm, larynx and throat irritation, wheezing, laryngeal edema, nausea, vomiting, diarrhea, hypertension, flushing, headache, pyrexia, chills, acute renal failure, hyperkalemia, hypocalcemia, hyperuricemia, hyperphosphatemia, serious bacterial infections, serious fungal infections, new or reactivated viral infections, fatal infections, late onset neutropenia, prolonged neutropenia, antimicrobial prophylaxis, antiviral prophylaxis, antifungal prophylaxis, acute thrombocytopenia, fatal hemorrhagic events, bleeding, hemorrhagic events, live virus vaccines, B-cell recovery"
92,ONGLYZA,adverse reactions,"upper respiratory tract infection, urinary tract infection, headache, peripheral edema, lymphopenia, rash, blood creatinine increased, blood creatine phosphokinase increased, sinusitis, abdominal pain, gastroenteritis, vomiting, fractures, thrombocytopenia, idiopathic thrombocytopenic purpura, hypoglycemia, hypersensitivity reactions, urticaria, facial edema, tuberculosis, salmonella sepsis, death, anaphylaxis, angioedema, exfoliative skin conditions, acute pancreatitis, severe and disabling arthralgia"
93,ONGLYZA,warnings and precautions,"acute pancreatitis, hypoglycemia, hypersensitivity-related events, urticaria, facial edema, anaphylaxis, angioedema, exfoliative skin conditions, arthralgia, severe joint pain, severe and disabling arthralgia"
94,SIVEXTRO,adverse reactions,"nausea, headache, diarrhea, vomiting, dizziness, anemia, palpitations, tachycardia, asthenopia, vision blurred, visual impairment, vitreous floaters, infusion-related reactions, drug hypersensitivity, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, white blood cell count decreased, hypoesthesia, paresthesia, VIIth nerve paralysis, insomnia, pruritus, urticaria, dermatitis, flushing, hypertension, myelosuppression, peripheral neuropathy, optic neuropathy"
95,SIVEXTRO,warnings and precautions,"neutropenia, Clostridium difficile-associated diarrhea, CDAD, mild diarrhea, fatal colitis, morbidity, mortality, drug-resistant bacteria, death"
96,PREPOPIK,adverse reactions,"nausea, headache, vomiting, abdominal bloating, distension, pain/cramping, watery diarrhea, electrolyte abnormalities, potassium (low), sodium (low), chloride (low), magnesium (high), calcium (low), creatinine (high), eGFR (low), allergic reactions, rash, urticaria, purpura, hypokalemia, hyponatremia, hypermagnesemia, abdominal pain, diarrhea, fecal incontinence, proctalgia, aphthoid ileal ulcers, ischemic colitis, seizures, generalized tonic-clonic seizures, death"
97,PREPOPIK,warnings and precautions,"fluid and electrolyte abnormalities, arrhythmia, seizures, renal impairment, mucosal ulcerations, GI obstruction, perforation, aspiration, dehydration, orthostatic hypotension, cardiac arrhythmias, generalized tonic-clonic seizures, hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, renal injury, colonic mucosal ulceration, ischemic colitis, ulcerative colitis, gastrointestinal obstruction, nausea, vomiting"
98,OFEV,adverse reactions,"Liver Enzyme and Bilirubin Elevations, Gastrointestinal Disorders, Embryofetal Toxicity, Arterial Thromboembolic Events, Risk of Bleeding, Gastrointestinal Perforation, diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, bronchitis, myocardial infarction, pneumonia, lung neoplasm malignant, hypothyroidism"
99,OFEV,warnings and precautions,"Elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, Gastrointestinal disorders, Diarrhea, Nausea, Vomiting, Embryofetal toxicity, Arterial thromboembolic events, Bleeding events, Gastrointestinal perforation, Liver enzyme increases, Myocardial infarction"
100,ZONTIVITY,adverse reactions,"Bleeding, life-threatening bleeding, fatal bleeding, death, GUSTO severe bleeding, intracranial bleeding, bleeding with hemodynamic compromise requiring intervention, GUSTO moderate bleeding, bleeding requiring transfusion, non-CABG-related bleeds, GUSTO Bleeding Categories, severe bleeding, moderate or severe bleeding, any GUSTO bleeding (severe/moderate/mild), fatal bleeding, intracranial hemorrhage (ICH), clinically significant bleeding, gastrointestinal bleeding, anemia, depression, rashes, eruptions, exanthemas, iron deficiency, retinopathy, retinal disorder, diplopia, oculomotor disturbances."
101,ZONTIVITY,boxed warnings,"bleeding, stroke, transient ischemic attack, intracranial hemorrhage, active pathological bleeding, fatal bleeding, death"
102,ZONTIVITY,warnings and precautions,"bleeding, ICH (intracranial hemorrhage), fatal bleeding, death"
103,BELVIQ,adverse reactions,"Serotonin Syndrome, NMS-like Reactions, Valvular Heart Disease, Cognitive Impairment, Psychiatric Disorders, Hypoglycemia, Heart Rate Decreases, Hematological Changes, Prolactin Elevation, headache, dizziness, fatigue, nausea, dry mouth, constipation, back pain, cough, diarrhea, vomiting, upper respiratory tract infection, nasopharyngitis, urinary tract infection, musculoskeletal pain, oropharyngeal pain, sinus congestion, rash, toothache, peripheral edema, seasonal allergy, gastroenteritis, worsening of diabetes mellitus, decreased appetite, muscle spasms, anxiety, insomnia, stress, depression, suicidality, euphoria, lymphocyte count decrease, neutrophil count decrease, hemoglobin decrease, eye disorders, blurred vision, dry eye, visual impairment, visual disorders, conjunctival infections, ocular sensation disorders, cataract conditions, aortic insufficiency, mitral insufficiency, valvulopathy"
104,BELVIQ,warnings and precautions,"Serotonin Syndrome, Neuroleptic Malignant Syndrome (NMS)-like Reactions, Valvular heart disease, Cognitive Impairment, disturbances in attention, memory impairment, Psychiatric Disorders, euphoria, dissociation, depression, suicidal thoughts, hypoglycemia, Priapism, prolonged erection, Heart Rate Decreases, bradycardia, Hematological Changes, leukopenia, lymphopenia, neutropenia, decreased white cell count, anemia, decreases in hemoglobin, decreases in hematocrit, Prolactin Elevation, galactorrhea, gynecomastia, prolactinoma, Pulmonary Hypertension, death"
105,STELARA,adverse reactions,"Infections, Malignancies, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Nasopharyngitis, Upper respiratory tract infection, Headache, Fatigue, Diarrhea, Back pain, Dizziness, Pharyngolaryngeal pain, Pruritus, Injection site erythema, Myalgia, Depression, Cellulitis, Herpes zoster, Diverticulitis, Injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, irritation), Arthralgia, Nausea, Dental infections, Serious hypersensitivity reactions (including anaphylaxis and angioedema), Other hypersensitivity reactions (including rash and urticaria), Pustular psoriasis, Erythrodermic psoriasis"
106,STELARA,warnings and precautions,"Infections, Serious infections, Clinically important active infection, Theoretical Risk for Particular Infections, Mycobacteria infections, Salmonella infections, Bacillus Calmette-Guerin (BCG) vaccinations, Tuberculosis (TB), Malignancies, Anaphylaxis, Clinically significant hypersensitivity reactions, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Serious bacterial infections, Fungal infections, Viral infections, Reactivation of latent infections, Diverticulitis, Cellulitis, Pneumonia, Appendicitis, Cholecystitis, Sepsis, Osteomyelitis, Gastroenteritis, Urinary tract infections, Disseminated infections, Fatal outcomes, Active tuberculosis, Latent tuberculosis, Non-melanoma skin cancer, Cutaneous squamous cell carcinomas, Hypersensitivity reactions, Angioedema, Headache, Seizures, Confusion, Visual disturbances, Preeclampsia, Eclampsia, Acute hypertension, Cytotoxic agents, Immunizations, Live vaccines, Non-live vaccinations, Death (due to fatal outcomes mentioned in the context of serious infections and RPLS)."
107,NATROBA,adverse reactions,"application site erythema, ocular erythema, application site irritation, application site dryness, application site exfoliation, alopecia, dry skin"
108,NATROBA,warnings and precautions,"Benzyl alcohol toxicity, serious adverse reactions, death"
109,ELELYSO,adverse reactions,"pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea, rash, urticaria, hypersensitivity reactions, severe vomiting, gastrointestinal inflammation, throat irritation, chest discomfort, anaphylaxis, Type III immune-mediated fixed drug eruption, death"
110,ELELYSO,warnings and precautions,"hypersensitivity reactions, anaphylaxis, urticaria, hypotension, flushing, wheezing, chest tightness, nausea, vomiting, dizziness, pruritus, angioedema, erythema, rash, cough, throat irritation"
111,STRIVERDI,adverse reactions,"asthma-related death, nasopharyngitis, upper respiratory tract infection, bronchitis, urinary tract infection, cough, dizziness, rash, diarrhea, back pain, arthralgia, COPD exacerbation, pneumonia, atrial fibrillation, constipation, pyrexia, lung cancers, death"
112,STRIVERDI,boxed warnings,"asthma-related death, death"
113,STRIVERDI,warnings and precautions,"acutely deteriorating COPD, cardiovascular effects, fatal, paradoxical bronchospasm, life-threatening, cardiovascular disorders, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, asthma-related death, deterioration of disease, acute episodes of bronchospasm, increased use of inhaled beta2-agonist, markers of deterioration of disease, excessive use of STRIVERDI RESPIMAT, overdose, fatalities, clinically significant cardiovascular effect, increases in pulse rate, systolic blood pressure, diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, coronary insufficiency, cardiac arrhythmias, hypertrophic obstructive cardiomyopathy, hypertension, convulsive disorders, thyrotoxicosis, prolongation of the QT interval, responsiveness to sympathomimetic amines, aggravation of pre-existing diabetes mellitus, ketoacidosis, hypokalemia, adverse cardiovascular effects, increases in plasma glucose, susceptibility for cardiac arrhythmias, decreases in serum potassium, changes in blood glucose, hypersensitivity reactions, angioedema, death"
114,BELSOMRA,adverse reactions,"CNS depressant effects, daytime impairment, abnormal thinking, behavioral changes, worsening of depression, suicidal ideation, sleep paralysis, hypnagogic hallucinations, hypnopompic hallucinations, cataplexy-like symptoms, somnolence, diarrhea, dry mouth, upper respiratory tract infection, headache, dizziness, abnormal dreams, cough, increase in serum cholesterol"
115,BELSOMRA,warnings and precautions,"Daytime somnolence, impaired alertness, motor coordination impairment, impaired driving, insomnia, nighttime ""sleep-driving"", complex behaviors while not fully awake, depression, worsening of depression, suicidal thinking, behavioral changes, compromised respiratory function, sleep paralysis, hypnagogic/hypnopompic hallucinations, cataplexy-like symptoms, CNS depressant effects, daytime impairment, somnolence, driving skills impairment, risk of falling asleep while driving, cognitive changes, amnesia, anxiety, hallucinations, neuro-psychiatric symptoms, suicidal ideation, suicidal thoughts, suicidal actions, death (due to mention of completed suicides), leg weakness."
116,NPLATE,adverse reactions,"arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia, headache, bone marrow reticulin deposition, worsening thrombocytopenia, erythromelalgia, hypersensitivity, angioedema"
117,NPLATE,warnings and precautions,"progression to acute myelogenous leukemia, increased blast cell counts, thrombotic complications, thromboembolic complications, portal vein thrombosis, worsened thrombocytopenia, formation of neutralizing antibodies, bone marrow reticulin formation, bone marrow fibrosis, lack or loss of response to Nplate, hyporesponsiveness, failure to maintain a platelet response, death"
118,ORBACTIV,adverse reactions,"Hypersensitivity Reactions, Infusion related reactions, Clostridium difficile-associated diarrhea, Osteomyelitis, Headache, Nausea, Vomiting, Limb and subcutaneous abscesses, Diarrhea, Cellulitis, Dizziness, Infusion site phlebitis, Infusion site reaction, Abscess, Alanine aminotransferase increased, Aspartate aminotransferase increased, Tachycardia, Anemia, Eosinophilia, Infusion site erythema, Extravasation, Induration, Pruritis, Rash, Edema peripheral, Hypersensitivity, Total bilirubin increased, Hyperuricemia, Hypoglycemia, Tenosynovitis, Myalgia, Bronchospasm, Wheezing, Urticaria, Angioedema, Erythema multiforme, Leucocytoclastic vasculitis"
119,ORBACTIV,warnings and precautions,"bleeding, aPTT prolongation, PT prolongation, INR prolongation, hypersensitivity reactions, infusion-related reactions, pruritus, urticaria, flushing, Clostridium difficile-associated diarrhea (CDAD), fatal colitis (death), osteomyelitis, drug-resistant bacteria"
120,MEKINIST,adverse reactions,"New Primary Malignancies, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Interstitial Lung Disease, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, rash, diarrhea, lymphedema, pyrexia, chills, fatigue, nausea, vomiting, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, myalgia, stomatitis, mouth ulceration, mucosal inflammation, aphthous stomatitis, dry skin, pruritus, paronychia, dermatitis acneiform, hypertension, epistaxis, gingival bleeding, hematochezia, rectal hemorrhage, melena, vaginal hemorrhage, hemorrhoidal hemorrhage, hematuria, conjunctival hemorrhage, bradycardia, xerostomia, folliculitis, rash pustular, cellulitis, rhabdomyolysis, dizziness, dysgeusia, vision blurred, dry eye, increased aspartate aminotransferase (AST), increased alanine aminotransferase (ALT), hypoalbuminemia, anemia, increased alkaline phosphatase, leukopenia, lymphopenia, neutropenia, thrombocytopenia, hyperbilirubinemia, hyperglycemia, increased gamma-glutamyltransferase (GGT), hyponatremia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, oropharyngeal pain, back pain, muscle spasms, pain in extremity, dehydration, insomnia, urinary tract infection, renal failure, transient blindness, pancreatitis, asthenia, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, QTc prolongation"
121,MEKINIST,warnings and precautions,"Tumor promotion, Hemolytic anemia, New primary malignancies, Hemorrhage, Major hemorrhagic events, Venous Thromboembolism, Deep vein thrombosis, Pulmonary embolism, Cardiomyopathy, Ocular Toxicities, Retinal Vein Occlusion (RVO), Interstitial Lung Disease (ILD), Pneumonitis, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Embryofetal Toxicity, Basal cell carcinoma, Cutaneous squamous cell carcinomas (SCC), Keratoacanthoma, New primary melanoma, Non-Cutaneous Malignancies, Pancreatic adenocarcinoma, Colorectal carcinoma, Head and neck carcinoma, Glioblastoma, Intracranial hemorrhage, Gastric hemorrhage, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Fever, Pyrexia, Hypotension, Rigors, Chills, Dehydration, Renal failure, Syncope, Dermatitis acneiform rash, Palmar-plantar erythrodysesthesia syndrome, Erythema, Abortifacient, death"
122,CYRAMZA,adverse reactions,"Hemorrhage, Arterial Thromboembolic Events, Hypertension, Infusion-Related Reactions, Gastrointestinal Perforation, Impaired Wound Healing, Cirrhosis, Reversible Posterior Leukoencephalopathy Syndrome, Proteinuria, Nephrotic Syndrome, Thyroid Dysfunction, Diarrhea, Fatigue, Neutropenia, Epistaxis, Decreased Appetite, Stomatitis, Mucosal Inflammation, Anemia, Intestinal Obstruction, Red Blood Cell Transfusions, Hyponatremia, Headache, Rash, Febrile Neutropenia, Granulocyte Colony-Stimulating Factors, Thrombocytopenia, Gastrointestinal Hemorrhage Events, Peripheral Edema, Hypoalbuminemia, Sepsis, Non-Small Cell Lung Cancer, Lacrimation Increased, Pulmonary Hemorrhage, Colorectal Cancer, Palmar-Plantar Erythrodysesthesia Syndrome, Increased TSH Levels"
123,CYRAMZA,boxed warnings,"hemorrhage, gastrointestinal hemorrhage, severe bleeding, fatal hemorrhagic events, gastrointestinal perforation, impaired wound healing, wound healing complications, death"
124,CYRAMZA,warnings and precautions,"Arterial Thromboembolic Events, ATEs, Hypertension, Infusion-Related Reactions, Impaired Wound Healing, Clinical Deterioration in Patients with Cirrhosis, Reversible Posterior Leukoencephalopathy Syndrome, Proteinuria, Nephrotic Syndrome, Thyroid Dysfunction, Embryofetal Risk, Hemorrhage, Gastrointestinal Hemorrhage, Hemorrhagic Events, Gastric Hemorrhage, Pulmonary Hemorrhage, Gastrointestinal Perforations, Encephalopathy, Ascites, Hepatorenal Syndrome, Hypothyroidism, death"
125,RAXIBACUMAB,adverse reactions,"rash, pain in extremity, pruritus, somnolence, urticaria, clonus, dyspnea, anemia, leukopenia, lymphadenopathy, palpitations, vertigo, fatigue, infusion site pain, peripheral edema, blood amylase increased, blood creatine phosphokinase increased, prothrombin time prolonged, back pain, muscle spasms, syncope vasovagal, insomnia, flushing, hypertension"
126,RAXIBACUMAB,warnings and precautions,"infusion reactions, rash, urticaria, pruritus"
127,ARCALYST,adverse reactions,"Mycobacterium intracellulare infection, gastrointestinal bleeding, colitis, sinusitis, bronchitis, Streptococcus pneumoniae meningitis, death, injection-site reaction (ISR), upper respiratory infection, nausea, diarrhea, abdominal pain upper, cough, hypoesthesia, stomach discomfort, urinary tract infection, erythema, swelling, pruritis, mass, bruising, inflammation, pain, edema, dermatitis, discomfort, urticaria, vesicles, warmth, hemorrhage, transient neutropenia"
128,ARCALYST,warnings and precautions,"serious infections, life-threatening infections, hypersensitivity reactions, bronchitis, bacterial meningitis, death, immunosuppression, increased risk of malignancies, ineffective vaccinations, changes in lipid profiles"
129,RAPIVAB,adverse reactions,"serious skin reactions, hypersensitivity reactions, neuropsychiatric events, diarrhea, alanine aminotransferase increased, serum glucose increased, creatine phosphokinase increased, neutropenia, constipation, insomnia, aspartate aminotransferase increased, hypertension, Stevens-Johnson Syndrome, exfoliative dermatitis, rash, abnormal behavior, hallucination"
130,RAPIVAB,warnings and precautions,"Stevens-Johnson syndrome, erythema multiforme, hallucinations, delirium, abnormal behavior, death (due to mention of fatal outcomes), serious skin reactions, neurologic symptoms, behavioral symptoms, encephalitis, encephalopathy, serious bacterial infections."
131,FOLOTYN,adverse reactions,"Bone Marrow Suppression, Mucositis, Dermatologic Reactions, Tumor Lysis Syndrome, Hepatic Toxicity, thrombocytopenia, nausea, fatigue, pyrexia, sepsis, febrile neutropenia, dehydration, dyspnea, anemia, constipation, edema, cough, epistaxis, vomiting, neutropenia, diarrhea, anorexia, hypokalemia, rash, pruritus, pharyngolaryngeal pain, liver function test abnormal, abdominal pain, pain in extremity, back pain, leukopenia, night sweats, asthenia, tachycardia, upper respiratory tract infection, cardiopulmonary arrest, pancytopenia, toxic epidermal necrolysis, death"
132,FOLOTYN,warnings and precautions,"thrombocytopenia, neutropenia, anemia, mucositis, dermatologic reactions, fatal reactions, death, tumor lysis syndrome, hepatic toxicity, liver function test abnormalities, increased toxicity with renal impairment, embryo-fetal toxicity, skin exfoliation, ulceration, toxic epidermal necrolysis (TEN), embryotoxic, fetotoxic"
133,KRYSTEXXA,adverse reactions,"anaphylaxis, infusion reactions, gout flares, nausea, contusion, ecchymosis, nasopharyngitis, constipation, chest pain, vomiting, congestive heart failure exacerbation, urticaria, dyspnea, erythema, pruritus, immunogenicity, anti-pegloticase antibodies, anti-PEG antibodies"
134,KRYSTEXXA,boxed warnings,"anaphylaxis, infusion reactions, delayed-type hypersensitivity reactions"
135,KRYSTEXXA,warnings and precautions,"Anaphylaxis, Infusion Reactions, Gout Flares, Congestive Heart Failure Exacerbation, Wheezing, Peri-oral Edema, Lingual Edema, Hemodynamic Instability, Rash, Urticaria, Delayed Type Hypersensitivity Reactions, Death (if anaphylaxis is fatal)"
136,NUCYNTA,adverse reactions,"Respiratory Depression, Interaction with Alcohol, Chronic Pulmonary Disease, Hypotensive Effects, Interactions with Other CNS Depressants, Drug abuse, addiction, dependence, Gastrointestinal Effects, Seizures, Serotonin Syndrome, nausea, dizziness, vomiting, somnolence, headache, Constipation, Dry mouth, Dyspepsia, Fatigue, Feeling hot, Nasopharyngitis, Upper respiratory tract infection, Urinary tract infection, Decreased appetite, Tremor, Lethargy, Insomnia, Confusional state, Abnormal dreams, Anxiety, Pruritus, Hyperhidrosis, Pruritus generalized, Rash, Hot flush, heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, feeling drunk, hypersensitivity, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, depressed level of consciousness, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, euphoric mood, disorientation, restlessness, agitation, nervousness, thinking abnormal, urinary hesitation, pollakiuria, oxygen saturation decreased, cough, dyspnea, respiratory depression, urticaria, blood pressure decreased, diarrhea, headache, hallucination, suicidal ideation, panic attack, palpitations, Anaphylaxis, angioedema, anaphylactic shock, death"
137,NUCYNTA,warnings and precautions,"misuse, abuse, addiction, overdose, death, respiratory depression, hypotension, sedation, coma, seizures, serotonin syndrome, withdrawal symptoms, anxiety, sweating, insomnia, rigors, pain, nausea, tremors, diarrhea, upper respiratory symptoms, piloerection, hallucinations, impaired mental abilities, impaired physical abilities, hepatic impairment, renal impairment"
138,ACTEMRA,adverse reactions,"upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions, serious infections, pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis, bacterial arthritis, opportunistic infections, gastrointestinal perforations, purulent peritonitis, lower GI perforation, fistula, abscess, infusion reactions, hypertension, skin reactions, rash, pruritus, urticaria, anaphylaxis, hypersensitivity reactions, neutropenia, thrombocytopenia, elevated liver enzymes, liver enzyme abnormalities, AST increased, ALT increased, lipids, elevated cholesterol, elevated LDL, elevated HDL, elevated triglycerides, immunogenicity, anti-tocilizumab antibodies, malignancies, dizziness, bronchitis, mouth ulceration, abdominal pain upper, gastritis, transaminase increased, weight increased, total bilirubin increased, leukopenia, edema peripheral, dyspnea, cough, conjunctivitis, nephrolithiasis, hypothyroidism, injection site reactions, erythema, pain, hematoma, macrophage activation syndrome, MAS, angioedema, Stevens-Johnson Syndrome, death"
139,ACTEMRA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, pulmonary disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, candidiasis, aspergillosis, pneumocystis, bacterial infections, viral infections, opportunistic pathogens, tuberculosis (TB)"
140,ACTEMRA,warnings and precautions,"Serious Infections, Gastrointestinal (GI) perforation, Laboratory monitoring, Hypersensitivity reactions, Anaphylaxis, Death, Live vaccines, Pneumonia, Urinary tract infection, Cellulitis, Herpes zoster, Gastroenteritis, Diverticulitis, Sepsis, Bacterial arthritis, Tuberculosis, Cryptococcus, Aspergillosis, Candidiasis, Pneumocystosis, Histoplasmosis, Coccidioidomycosis, Listeriosis, Viral Reactivation, Hepatitis B reactivation, Neutropenia, Thrombocytopenia, Elevated Liver Enzymes, Lipid Abnormalities, Immunosuppression, Malignancies, Demyelinating Disorders, Active Hepatic Disease, Hepatic Impairment, Vaccinations"
141,VIIBRYD,adverse reactions,"Suicidal Thoughts and Behaviors, Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania or Hypomania, Discontinuation Syndrome, Seizures, Angle-Closure Glaucoma, Hyponatremia, diarrhea, nausea, vomiting, insomnia, abdominal pain, dyspepsia, flatulence, gastroenteritis, abdominal distension, headache, dizziness, somnolence, paresthesia, abnormal dreams, restlessness, fatigue, palpitations, increased appetite, arthralgia, increased weight, abnormal orgasm, anorgasmia, erectile dysfunction, libido decreased, ejaculation disorder, ventricular extrasystoles, dry eye, vision blurred, cataracts, sedation, tremor, migraine, panic attack, hyperhidrosis, night sweats, irritability, hallucinations, suicide attempt, suicidal ideation, rash, generalized rash, urticaria, drug eruption, death"
142,VIIBRYD,boxed warnings,"suicidal thoughts, suicidal behaviors, clinical worsening"
143,VIIBRYD,warnings and precautions,"Serotonin Syndrome, Increased Risk of Bleeding, Activation of Mania/Hypomania, Seizures, Angle Closure Glaucoma, Suicidal Thoughts and Behavior, Discontinuation Syndrome, Hyponatremia, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dysphoric mood, irritability, sensory disturbances, paresthesia, electric shock sensations, anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, difficulty concentrating, memory impairment, weakness, unsteadiness, falls, hallucination, syncope, respiratory arrest, death"
144,LUZU,adverse reactions,"application site reactions, contact dermatitis, cellulitis, death"
145,LUMASON,adverse reactions,"severe cardiopulmonary reactions, hypersensitivity reactions, headache, nausea, hypersensitivity-type rash, near syncope, anaphylactic shock, dysgeusia, injection site pain, chest discomfort, feeling hot, chest pain, injection site warmth, fatalities, anaphylactoid reactions, arrhythmias, hypertensive episodes, death"
146,LUMASON,boxed warnings,"serious cardiopulmonary reactions, fatalities, death"
147,LUMASON,warnings and precautions,"Cardiopulmonary reactions, fatalities, death, Anaphylactoid reactions, fatal cardiac arrest, respiratory arrest, shock, syncope, symptomatic arrhythmias, atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia, hypertension, hypotension, dyspnea, hypoxia, chest pain, respiratory distress, stridor, wheezing, loss of consciousness, convulsions, skin erythema, rash, urticaria, flushing, throat tightness, anaphylactic shock, systemic embolization, tissue ischemia, microsphere cavitation, rupture, ventricular arrhythmias."
148,LYNPARZA,adverse reactions,"Myelodysplastic syndrome, Acute Myeloid Leukemia, Pneumonitis, Anemia, Nausea, Fatigue, Asthenia, Vomiting, Diarrhea, Dysgeusia, Dyspepsia, Headache, Decreased appetite, Nasopharyngitis, Pharyngitis, Upper Respiratory Infection (URI), Cough, Arthralgia, Musculoskeletal pain, Myalgia, Back pain, Dermatitis, Rash, Abdominal pain, Discomfort, Increase in creatinine, Mean corpuscular volume elevation, Decrease in hemoglobin, Decrease in lymphocytes, Decrease in absolute neutrophil count, Decrease in platelets, COPD, Cerebrovascular accident, Intestinal perforation, Pulmonary embolism, Sepsis, Suture rupture, Constipation, Peripheral edema, Dizziness, Urinary tract infection, Dyspnea, Leukopenia, Stomatitis, Peripheral neuropathy, Pyrexia, Hypomagnesemia, Hyperglycemia, Anxiety, Depression, Insomnia, Dysuria, Urinary incontinence, Vulvovaginal disorder, Dry skin, Eczema, Pruritis, Hypertension, Venous thrombosis, Hot flush, Death"
149,LYNPARZA,warnings and precautions,"Myelodysplastic syndrome, Acute Myeloid Leukemia, MDS/AML, Pneumonitis, Embryo-Fetal toxicity, fetal harm, hematological toxicity, death"
150,EGRIFTA,adverse reactions,"hypersensitivity, rash, urticaria, arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome, injection site reactions, injection site erythema, pruritus, pain, irritation, swelling, hemorrhage, myalgia, musculoskeletal pain, musculoskeletal stiffness, joint stiffness, muscle spasms, joint swelling, edema peripheral, injection site pain, injection site irritation, chest pain, injection site rash, paresthesia, hypoesthesia, nausea, vomiting, dyspepsia, abdominal pain upper, palpitations, depression, night sweats, hypertension, muscle strain, blood creatine phosphokinase increased, neuropathy peripheral, insomnia, hot flush"
151,EGRIFTA,warnings and precautions,"neoplasms, elevated IGF-1, fluid retention, edema, arthralgia, carpal tunnel syndrome, glucose intolerance, hypersensitivity reactions, rash, urticaria, injection site reactions, acute critical illness, pruritus, erythema, flushing, pain, irritation, bruising, increased mortality, complications following open heart surgery, abdominal surgery, multiple accidental trauma, acute respiratory failure"
152,ELLA,adverse reactions,"headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness, upper abdominal pain, acne"
153,ELLA,warnings and precautions,"ectopic pregnancy, lower abdominal pain, altered menstrual cycle, delayed menses, intermenstrual bleeding"
154,ZALTRAP,adverse reactions,"Hemorrhage, Gastrointestinal Perforation, Compromised Wound Healing, Fistula Formation, Hypertension, Arterial Thromboembolic Events, Proteinuria, Neutropenia, Neutropenic Complications, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), leukopenia, AST increased, stomatitis, fatigue, thrombocytopenia, ALT increased, weight decreased, decreased appetite, epistaxis, abdominal pain, dysphonia, serum creatinine increased, headache, asthenia, infections, venous thromboembolic events, Urinary Tract Infection, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Vascular disorders, Respiratory, thoracic and mediastinal disorders, Dyspnea, Oropharyngeal Pain, Rhinorrhea, Gastrointestinal disorders, Abdominal Pain Upper, Hemorrhoids, Rectal Hemorrhage, Proctalgia, Skin and subcutaneous tissue disorders, Palmar-Plantar Erythrodysesthesia Syndrome, Skin Hyperpigmentation, Renal and urinary disorders, General disorders and administration site conditions, Investigations, hypersensitivity reactions, deep venous thrombosis, pulmonary embolism, Immunogenicity, anti-product antibody (APA), neutralizing antibodies."
155,ZALTRAP,boxed warnings,"hemorrhage, gastrointestinal hemorrhage, GI bleeding, severe bleeding, gastrointestinal perforation, GI perforation, compromised wound healing, death"
156,ZALTRAP,warnings and precautions,"Fistula Formation, Hypertension, Arterial Thromboembolic Events, ATE, transient ischemic attacks, cerebrovascular accident, angina pectoris, Proteinuria, nephrotic syndrome, thrombotic microangiopathy, TMA, Neutropenia, Neutropenic Complications, febrile neutropenia, neutropenic infection, sepsis, Diarrhea, Dehydration, Reversible Posterior Leukoencephalopathy Syndrome, RPLS, Hemorrhage, hemorrhagic events, gastrointestinal hemorrhage, hematuria, post-procedural hemorrhage, intracranial hemorrhage, pulmonary hemorrhage, hemoptysis, Gastrointestinal Perforation, GI perforation, Compromised Wound Healing, death"
157,MYRBETRIQ,adverse reactions,"hypertension, nasopharyngitis, urinary tract infection, headache, nausea, diarrhea, constipation, dizziness, tachycardia, atrial fibrillation, prostate cancer, constipation, upper respiratory tract infection, arthralgia, abdominal pain, fatigue, palpitations, blood pressure increased, glaucoma, dyspepsia, gastritis, abdominal distension, sinusitis, rhinitis, GGT increased, AST increased, ALT increased, LDH increased, nephrolithiasis, bladder pain, vulvovaginal pruritus, vaginal infection, urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema, back pain, dry mouth, sinusitis, influenza, cystitis, dry eyes, vision blurred, cerebrovascular accident, osteoarthritis, neoplasm, breast cancer, lung neoplasm malignant, Stevens-Johnson syndrome, angioedema, urinary retention"
158,MYRBETRIQ,warnings and precautions,"Increases in Blood Pressure, Urinary Retention, Angioedema, Worsening of pre-existing hypertension, upper airway swelling, death"
159,EDURANT,adverse reactions,"Skin and Hypersensitivity Reactions, Depressive Disorders, Hepatotoxicity, headache, insomnia, rash, abdominal pain, nausea, vomiting, fatigue, dizziness, abnormal dreams, diarrhea, abdominal discomfort, cholecystitis, cholelithiasis, decreased appetite, somnolence, sleep disorders, anxiety, glomerulonephritis membranous, glomerulonephritis mesangioproliferative, nephrolithiasis, nephrotic syndrome, Severe skin and hypersensitivity reactions, DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)"
160,EDURANT,warnings and precautions,"Torsade de Pointes, Severe skin reactions, Hypersensitivity reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Rash with systemic symptoms, Elevations in hepatic serum biochemistries, Severe depressive disorders, Depressed mood, Depression, Dysphoria, Major depression, Mood altered, Negative thoughts, Suicide attempt, Suicidal ideation, Hepatotoxicity, Hepatic adverse events, Hepatitis B, Hepatitis C, Transaminase elevations, Hepatic toxicity, Redistribution/accumulation of body fat, Central obesity, Dorsocervical fat enlargement (buffalo hump), Peripheral wasting, Facial wasting, Breast enlargement, Cushingoid appearance, Immune reconstitution syndrome, Inflammatory response, Mycobacterium avium infection, Cytomegalovirus, Pneumocystis jiroveci pneumonia, Tuberculosis, Autoimmune disorders, Graves' disease, Polymyositis, Guillain-Barre syndrome."
161,HARVONI,adverse reactions,"fatigue, headache, nausea, diarrhea, insomnia, bilirubin elevations, lipase elevations, creatine kinase elevations, serious symptomatic bradycardia"
162,HARVONI,warnings and precautions,"serious symptomatic bradycardia, fatal cardiac arrest, pacemaker intervention, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems, death"
163,OSPHENA,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, hot flush, vaginal discharge, muscle spasms, genital discharge, hyperhidrosis, thromboembolic stroke, hemorrhagic stroke, deep vein thrombosis (DVT), allergic conditions, hypersensitivity, angioedema, rash, rash erythematous, rash generalized, pruritus, urticaria"
164,OSPHENA,boxed warnings,"endometrial cancer, cardiovascular disorders, stroke, deep vein thrombosis (DVT), thromboembolic stroke, hemorrhagic stroke, endometrial hyperplasia"
165,OSPHENA,warnings and precautions,"Venous Thromboembolism, DVT, pulmonary embolism, breast cancer, Severe Hepatic Impairment, Cardiovascular Disorders, arterial vascular disease, hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, obesity, venous thromboembolism, personal history of VTE, family history of VTE, systemic lupus erythematosus, Stroke, thromboembolic stroke, hemorrhagic stroke, Coronary Heart Disease, nonfatal MI, silent MI, CHD death, Malignant Neoplasms, Endometrial Cancer, simple hyperplasia without atypia, endometrial thickening, proliferative endometrium, Uterine polyps, endometrial hyperplasia, breast cancer, abnormal genital bleeding, Severe Hepatic Impairment"
166,ERIVEDGE,adverse reactions,"muscle spasms, alopecia, dysgeusia, weight loss, fatigue, nausea, diarrhea, decreased appetite, constipation, arthralgias, vomiting, ageusia, amenorrhea, hyponatremia, hypokalemia, azotemia"
167,ERIVEDGE,boxed warnings,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, severe midline defects, missing digits, irreversible malformations, death"
168,ERIVEDGE,warnings and precautions,"embryo-fetal death, severe birth defects, embryotoxic, fetotoxic, teratogenic, death"
169,LATUDA,adverse reactions,"Increased Mortality in Elderly Patients with Dementia-Related Psychosis, Suicidal Thoughts and Behaviors, Cerebrovascular Adverse Reactions, Stroke, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, Weight Gain, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Dysregulation, Suicide, Activation of Mania, Hypomania, Dysphagia, Neurological Adverse Reactions, Parkinson's Disease, Dementia with Lewy Bodies, somnolence, akathisia, extrapyramidal symptoms, nausea, vomiting, diarrhea, anxiety, salivary hypersecretion, back pain, dizziness, insomnia, agitation, restlessness, dry mouth, nasopharyngitis, influenza, urinary tract infection, fatigue, increased appetite, weight increased, dystonia, oculogyric crisis, oromandibular dystonia, tongue spasm, torticollis, trismus, bradykinesia, cogwheel rigidity, drooling, hypokinesia, muscle rigidity, parkinsonism, psychomotor retardation, tremor, abnormal dreams, panic attack, sleep disorder, dysuria, renal failure, amenorrhea, dysmenorrhea, breast enlargement, breast pain, galactorrhea, erectile dysfunction, rash, pruritus, angioedema, hypertension, sudden death, anemia, tachycardia, AV block 1st degree, angina pectoris, bradycardia, vertigo, blurred vision, abdominal pain, gastritis, CPK increased, rhabdomyolysis, cerebrovascular accident, dysarthria, death"
170,LATUDA,boxed warnings,"increased mortality, death, dementia-related psychosis, suicidal thoughts, suicidal behaviors, risk of death, increased risk of suicidal thinking, increased risk of suicidal behavior, worsening, emergence of suicidal thoughts, emergence of suicidal behaviors"
171,LATUDA,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, Metabolic Changes, Hyperprolactinemia, Leukopenia, Neutropenia, Agranulocytosis, Orthostatic Hypotension, Syncope, dizziness, tachycardia, bradycardia, death, Suicidal Thoughts and Behaviors, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, psychomotor restlessness, hypomania, mania, seizures, cognitive impairment, motor impairment, body temperature dysregulation, suicide, activation of mania/hypomania, Dysphagia, aspiration pneumonia, confusion, obtundation, postural instability, falls, extrapyramidal symptoms, neuroleptic malignant syndrome"
172,LEXISCAN,adverse reactions,"Myocardial Ischemia, Sinoatrial Block, Atrioventricular Nodal Block, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, Hypotension, Hypertension, Bronchoconstriction, Seizure, Cerebrovascular Accident, Stroke, Dyspnea, Headache, Flushing, Chest Discomfort, Dizziness, Angina Pectoris, Chest Pain, Nausea, Abdominal Discomfort, Dysgeusia, Feeling Hot, ECG Abnormalities, Rhythm Abnormalities, PACs, PVCs, First-degree AV Block, Second-degree AV Block, AV Conduction Abnormalities, Ventricular Conduction Abnormalities, Respiratory Abnormalities, Wheezing, Obstructive Airway Disorder, Dyspnea Exertional, Tachypnea, Renal Impairment, Myocardial Infarction, Cardiac Arrest, Ventricular Arrhythmias, Supraventricular Tachyarrhythmias, Heart Block, Third-degree Block, Asystole, Marked Hypertension, Symptomatic Hypotension, Transient Ischemic Attack, QTc Prolongation, Tremor, Transient Ischemic Attack, Intracranial Hemorrhage, Abdominal Pain, Vomiting, Myalgias, Diarrhea, Fecal Incontinence, Angioedema, Respiratory Arrest, Respiratory Distress, Decreased Oxygen Saturation, Throat Tightness, Urticaria, Rashes, Musculoskeletal Pain, Respiratory Arrest, Wheezing, Death"
173,LEXISCAN,warnings and precautions,"Myocardial Ischemia, Fatal cardiac events, unstable angina, cardiovascular instability, Sinoatrial (SA) Nodal Block, Atrioventricular (AV) Nodal Block, first-degree AV block, second-degree AV block, third-degree AV block, sinus bradycardia, Atrial Fibrillation, Atrial Flutter, Hypersensitivity, Anaphylaxis, angioedema, cardiac arrest, respiratory arrest, respiratory distress, decreased oxygen saturation, hypotension, throat tightness, urticaria, rashes, Hypertension, Bronchoconstriction, dyspnea, respiratory compromise, Seizure, convulsive seizures, Cerebrovascular Accident, Stroke, Hemorrhagic stroke, ischemic stroke, nonfatal myocardial infarction, ventricular arrhythmias, PR prolongation, asystole, syncope, transient ischemic attacks, death"
174,BRILINTA,adverse reactions,"Bleeding, Dyspnea, Fatal/Life-threatening, Fatal, Intracranial hemorrhage, Major bleed, Minor bleed, Dizziness, Nausea, Bradycardia, Syncope, Pre-syncope, Loss of consciousness, Gout, Serum Uric Acid increase, Serum Creatinine increase, Diarrhea, death"
175,BRILINTA,boxed warnings,"significant bleeding, fatal bleeding, active pathological bleeding, history of intracranial hemorrhage, urgent coronary artery bypass graft surgery, cardiovascular events, reduced effectiveness of BRILINTA, death"
176,BRILINTA,warnings and precautions,"dyspnea, severe hepatic impairment, risk of bleeding, myocardial infarction, stroke, death"
177,KERYDIN,adverse reactions,"application site exfoliation, ingrown toenail, application site erythema, application site dermatitis, skin irritation"
178,ZELBORAF,adverse reactions,"New Primary Malignancies, Hypersensitivity Reactions, Dermatologic Reactions, QT Prolongation, Hepatotoxicity, Photosensitivity, Ophthalmologic Reactions, Radiation Sensitization, Radiation Recall, arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus, skin papilloma, cuSCC, hyperkeratosis, rash maculo-papular, actinic keratosis, dry skin, rash papular, erythema, myalgia, pain in extremity, musculoskeletal pain, back pain, edema peripheral, pyrexia, asthenia, diarrhea, vomiting, constipation, headache, dysgeusia, skin papilloma, cutaneous SCC, seborrheic keratosis, gamma-glutamyltransferase increased, decreased appetite, cough, sunburn, palmar-plantar erythrodysesthesia syndrome, keratosis pilaris, panniculitis, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, arthritis, neuropathy peripheral, VIIth nerve paralysis, basal cell carcinoma, oropharyngeal squamous cell carcinoma, folliculitis, retinal vein occlusion, vasculitis, atrial fibrillation, GGT increase, AST increase, ALT increase, alkaline phosphatase increase, bilirubin increase, progression of pre-existing chronic myelomonocytic leukemia with NRAS mutation, DRESS syndrome, neutropenia, pancreatitis."
179,ZELBORAF,warnings and precautions,"Cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, non-cutaneous squamous cell carcinoma, other malignancies, tumor promotion in BRAF wild-type melanoma, serious hypersensitivity reactions, anaphylaxis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), severe dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, QT prolongation, hepatotoxicity, photosensitivity, serious ophthalmologic reactions, uveitis, embryo-fetal toxicity, radiation sensitization, radiation recall"
180,FYCOMPA,adverse reactions,"Serious Psychiatric and Behavioral Reactions, Suicidal Behavior and Ideation, Dizziness, Gait Disturbance, Somnolence, Fatigue, Falls, Nausea, Weight Gain, Vertigo, Ataxia, Headache, Vomiting, Contusion, Abdominal Pain, Anxiety, Aggression, Anger, Blurred Vision, Dysarthria, Balance Disorder, Back Pain, Hypersomnia, Cough, Upper Respiratory Tract Infection, Diplopia, Head Injury, Hypoaesthesia, Pain in Extremity, Constipation, Myalgia, Coordination Abnormal, Euphoric Mood, Confusional State, Hyponatremia, Limb Injury, Mood Altered, Arthralgia, Asthenia, Memory Impairment, Musculoskeletal Pain, Oropharyngeal Pain, Paraesthesia, Peripheral Edema, Skin Laceration, Ligament Sprain, Rash, Elevated Triglycerides, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)"
181,FYCOMPA,boxed warnings,"aggression, hostility, irritability, anger, homicidal ideation, threats, serious psychiatric and behavioral adverse reactions, changes in mood, behavior, personality changes, death"
182,FYCOMPA,warnings and precautions,"suicidal thoughts, suicidal behavior, suicidal ideation, dizziness, gait disturbance, somnolence, fatigue, falls, injuries, seizure frequency increase, hostility, aggression, hostility- and aggression-related adverse reactions, irritability, anger, anxiety, belligerence, affect lability, agitation, physical assault, homicidal ideation, homicidal threat, paranoia, euphoric mood, mental status changes, disorientation, confusional state, disorientation, delusion, vertigo, ataxia, balance disorder, abnormal coordination, asthenia, lethargy, head injuries, bone fracture, death"
183,ISTODAX,adverse reactions,"Myelosuppression, Infection, Electrocardiographic Changes, Tumor Lysis Syndrome, Neutropenia, Lymphopenia, Thrombocytopenia, Nausea, Fatigue, Vomiting, Anorexia, Anemia, ECG T-wave changes, Asthenia, Hypomagnesemia, Diarrhea, Pyrexia, Dysgeusia, Constipation, Hypotension, Pruritus, Hypokalemia, Dermatitis, Exfoliative dermatitis, Hypocalcemia, Leukopenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Hypoalbuminemia, Electrocardiogram ST-T wave changes, Hyperglycemia, Hyponatremia, Hypermagnesemia, Hypophosphatemia, Hyperuricemia, Sepsis, Supraventricular arrhythmia, Central line infection, Edema, Ventricular arrhythmia, Dehydration, Catheter related infection, Dyspnea, QT prolongation, Gastrointestinal disorders, Abdominal pain, Stomatitis, General disorders and administration site conditions, Chills, Edema peripheral, Blood and lymphatic system disorders, Metabolism and nutrition disorders, Nervous system disorders, Headache, Respiratory, thoracic and mediastinal disorders, Cough, Investigations, Weight decreased, Cardiac disorders, Tachycardia, Pneumonia, Cellulitis, Deep vein thrombosis, Febrile neutropenia, Chest pain, Pulmonary embolism, Hyperbilirubinemia, Hypoxia, Hypersensitivity, Packed red blood cell transfusion, Platelet transfusion, Reactivation of hepatitis B virus infection, Multi-organ failure, Septic shock, Candida sepsis, Cardiogenic shock, Epstein Barr virus reactivation, Death."
184,ISTODAX,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infections, fatal infections, serious infections, pneumonia, sepsis, viral reactivation, Epstein Barr virus reactivation, hepatitis B virus reactivation, liver failure, Electrocardiographic changes, T-wave changes, ST-segment changes, long QT syndrome, cardiovascular disease, QT prolongation, Tumor lysis syndrome, TLS, embryo-fetal toxicity, fetal harm, embryocidal, adverse effects on the developing fetus, death"
185,ZIOPTAN,adverse reactions,"conjunctival hyperemia, ocular stinging/irritation, ocular pruritus, allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, vision blurred, headache, common cold, cough, urinary tract infection, exacerbation of asthma, dyspnea, iritis, uveitis, periorbital changes, lid changes, deepening of the eyelid sulcus"
186,ZIOPTAN,warnings and precautions,"Pigmentation of the iris, periorbital tissue pigmentation, eyelash pigmentation, increased length of eyelashes, increased thickness of eyelashes, increased number of eyelashes, iris color change, intraocular inflammation, iritis, uveitis, macular edema, cystoid macular edema, death (not mentioned, so not included)."
187,SIGNIFOR,adverse reactions,"Hypocortisolism, Hyperglycemia, Diabetes, Bradycardia, QT prolongation, Liver Test Elevations, Cholelithiasis, Pituitary Hormone Deficiency, Diarrhea, Nausea, Headache, Abdominal pain, Fatigue, Diabetes mellitus, Injection site reactions, Nasopharyngitis, Alopecia, Asthenia, Glycosylated hemoglobin increased, Alanine aminotransferase increased, Gamma-glutamyl transferase increased, Edema peripheral, Abdominal pain upper, Decreased appetite, Hypercholesterolemia, Hypertension, Dizziness, Hypoglycemia, Type 2 diabetes mellitus, Anxiety, Influenza, Insomnia, Myalgia, Arthralgia, Pruritus, Lipase increased, Constipation, Hypotension, Vomiting, Back pain, Dry skin, Electrocardiogram QT prolonged, Hypokalemia, Pain in extremity, Sinus bradycardia, Vertigo, Abdominal distension, Adrenal insufficiency, Aspartate aminotransferase increased, Blood glucose increased, Anemia, Blood amylase increased, Prothrombin time prolonged, Gastrointestinal Disorders, Elevated Liver Tests, Hypocortisolism, Injection Site Reactions, Thyroid Function, Other Abnormal Laboratory Findings"
188,SIGNIFOR,warnings and precautions,"hypocortisolism, biochemical hypocortisolism, clinical hypocortisolism, hyperglycemia, diabetes, bradycardia, QT prolongation, liver test elevations, cholelithiasis, hypokalemia, hypomagnesemia, weakness, fatigue, anorexia, nausea, vomiting, hypotension, hyponatremia, hypoglycemia, severe hyperglycemia, ketoacidosis, high-grade heart block, myocardial infarction, congestive heart failure, unstable angina, transaminase elevation, ALT elevation, AST elevation, bilirubin elevation, deficiency of pituitary hormones, TSH/free T4 imbalance, GH/IGF-1 imbalance"
189,SOVALDI,adverse reactions,"Serious Symptomatic Bradycardia, fatigue, headache, nausea, insomnia, anemia, pruritus, asthenia, rash, decreased appetite, chills, influenza-like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability, pancytopenia, severe depression, suicidal ideation, suicide, hematologic effects, laboratory abnormalities, bilirubin elevations, creatine kinase elevations, lipase elevations, cardiac disorders, death"
190,SOVALDI,warnings and precautions,"serious symptomatic bradycardia, bradycardia, pacemaker intervention, fatal cardiac arrest, death, near-fainting, fainting, dizziness, lightheadedness, malaise, weakness, excessive tiredness, shortness of breath, chest pains, confusion, memory problems"
191,OLYSIO,adverse reactions,"Serious Symptomatic Bradycardia, Hepatic Decompensation, Hepatic Failure, Photosensitivity, Rash, Pruritus, Nausea, Fatigue, Headache, Myalgia, Dyspnea, Alkaline Phosphatase Elevation, Hyperbilirubinemia, Insomnia, Dizziness, Diarrhea, Cardiac Disorders, Hepatobiliary Disorders"
192,OLYSIO,warnings and precautions,"Serious symptomatic bradycardia, Hepatic decompensation, Hepatic failure, Photosensitivity reactions, Rash, Fatal cardiac arrest, Symptomatic bradycardia, Pacemaker intervention, Cardiac arrest, Near-fainting, Fainting, Dizziness, Lightheadedness, Malaise, Weakness, Excessive tiredness, Shortness of breath, Chest pain, Confusion, Memory problems, Elevated bilirubin levels, Fatigue, Lack of appetite, Nausea and vomiting, Jaundice, Discolored feces, Exaggerated sunburn reaction, Burning, Erythema, Exudation, Blistering, Edema, Severe rash, Mucosal signs, Oral lesions, Conjunctivitis, Systemic symptoms, Sulfa allergy, death"
193,PLEGRIDY,adverse reactions,"Hepatic Injury, Depression, Suicide, Seizures, Anaphylaxis, Allergic Reactions, Injection Site Reactions, Congestive Heart Failure, Decreased Peripheral Blood Counts, Autoimmune Disorders, Injection site erythema, Influenza-like illness, Pyrexia, Headache, Myalgia, Chills, Injection site pain, Asthenia, Injection site pruritus, Arthralgia, Nausea, Vomiting, Hyperthermia, Pain, Injection site edema, Injection site warmth, Injection site hematoma, Injection site rash, Body temperature increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyl-transferase increased, Pruritus"
194,PLEGRIDY,warnings and precautions,"hepatic injury, liver function tests abnormalities, signs and symptoms of hepatic injury, hepatitis, autoimmune hepatitis, severe hepatic failure, asymptomatic elevation of hepatic transaminases, elevations in hepatic enzymes, increases in hepatic transaminases, elevations of alanine aminotransferase, elevations of aspartate aminotransferase, elevated bilirubin, depression, suicide, suicidal ideation, seizure, anaphylaxis, allergic reactions, serious allergic reactions, angioedema, urticaria, injection site reactions, injection site necrosis, injection site erythema, injection site pain, injection site pruritus, injection site edema, congestive heart failure, cardiomyopathy, decreased peripheral blood counts, pancytopenia, severe thrombocytopenia, decreases in white blood cell counts, clinically significant decreases in lymphocyte counts, neutrophil counts, platelet counts, severe neutropenia, infections, bleeding, symptoms of anemia, autoimmune disorders, idiopathic thrombocytopenia, hyperthyroidism, hypothyroidism"
195,VIBATIV,adverse reactions,"Nephrotoxicity, Infusion-related reactions, Clostridium difficile-associated diarrhea, Diarrhea, Taste disturbance, Nausea, Vomiting, Foamy urine, Rigors, Decreased appetite, Renal System, Renal Failure Acute, Renal impairment, Renal insufficiency, Renal failure, Increased serum creatinine, Serious hypersensitivity reactions, Anaphylactic reactions, Death"
196,VIBATIV,boxed warnings,"increased mortality, nephrotoxicity, new onset renal impairment, worsening renal impairment, adverse developmental outcomes, death"
197,VIBATIV,warnings and precautions,"decreased efficacy, moderate/severe pre-existing renal impairment, hypersensitivity reactions, serious hypersensitivity reactions, fatal hypersensitivity reactions, anaphylactic reactions, infusion-related reactions, Clostridium difficile-associated disease, mild diarrhea, fatal colitis, coagulation test interference, QTc prolongation, increased mortality, nephrotoxicity, renal adverse events, renal dysfunction, accumulation of hydroxypropyl-beta-cyclodextrin, adverse developmental outcomes, coagulation tests affected, bleeding risk, hypercoagulability, anaphylactic reactions, skin rash, hypersensitivity, Red-man Syndrome, flushing, urticaria, pruritus, rash, Clostridium difficile-associated diarrhea (CDAD), morbidity, mortality, colectomy, drug-resistant bacteria, superinfection, fungi, death"
198,KIT,adverse reactions,"injection site irritation, pain"
199,KIT,warnings and precautions,"hypersensitivity reactions, serious hypersensitivity reactions, cancer, excessive radiation exposure, death"
200,HETLIOZ,adverse reactions,"headache, increased alanine aminotransferase, nightmares, unusual dreams, upper respiratory tract infection, urinary tract infection"
201,HETLIOZ,warnings and precautions,somnolence
202,VOTRIENT,adverse reactions,"diarrhea, hypertension, hair color changes, depigmentation, nausea, anorexia, vomiting, fatigue, decreased weight, decreased appetite, tumor pain, dysgeusia, headache, musculoskeletal pain, myalgia, gastrointestinal pain, dyspnea, hepatotoxicity, QT prolongation, torsades de pointes, cardiac dysfunction, hemorrhagic events, arterial thromboembolic events, venous thromboembolic events, thrombotic microangiopathy, gastrointestinal perforation, fistula, interstitial lung disease, pneumonitis, reversible posterior leukoencephalopathy syndrome, infection, increased toxicity with other cancer therapies, asthenia, abdominal pain, alopecia, chest pain, dysphonia, facial edema, palmar-plantar erythrodysesthesia, hand-foot syndrome, proteinuria, rash, skin depigmentation, weight decreased, arthralgia, muscle spasms, leukopenia, neutropenia, thrombocytopenia, lymphocytopenia, ALT increased, AST increased, glucose increased, total bilirubin increased, phosphorus decreased, sodium decreased, magnesium decreased, glucose decreased, exfoliative rash, cough, peripheral edema, mucositis, dizziness, skin disorder, stomatitis, insomnia, hypothyroidism, epistaxis, left ventricular dysfunction, dyspepsia, dry skin, chills, vision blurred, nail disorder, lipase elevations, pancreatitis, pneumothorax, bradycardia, retinal detachment, tear"
203,VOTRIENT,boxed warnings,"hepatotoxicity, severe hepatotoxicity, fatal hepatotoxicity, death"
204,VOTRIENT,warnings and precautions,"Increases in serum transaminase levels, bilirubin, severe hepatotoxicity, fatal hepatotoxicity, prolonged QT intervals, torsades de pointes, cardiac dysfunction, congestive heart failure, decreased left ventricular ejection fraction (LVEF), fatal hemorrhagic events, arterial thromboembolic events, fatal arterial thromboembolic events, venous thromboembolic events (VTE), fatal pulmonary emboli (PE), thrombotic microangiopathy (TMA), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), gastrointestinal perforation, fistula, fatal perforation events, interstitial lung disease (ILD), pneumonitis, fatal ILD/pneumonitis, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), fatal RPLS, hypertension, hypertensive crisis, hypothyroidism, proteinuria, nephrotic syndrome, serious infections, fatal infections, death"
205,JAKAFI,adverse reactions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Symptom Exacerbation, Non-Melanoma Skin Cancer, Bruising, Dizziness, Headache, Urinary Tract Infections, Weight Gain, Flatulence, Herpes Zoster, Alanine Transaminase (ALT) elevation, Aspartate Transaminase (AST) elevation, Cholesterol elevation, Abdominal Pain, Diarrhea, Fatigue, Pruritus, Dyspnea, Muscle Spasms, Nasopharyngitis, Constipation, Cough, Edema, Arthralgia, Asthenia, Epistaxis, Nausea, Weight gain, Hypertension, Hypercholesterolemia, Elevated ALT, Elevated AST, Hypertriglyceridemia"
206,JAKAFI,warnings and precautions,"Thrombocytopenia, Anemia, Neutropenia, Risk of Infection, Serious bacterial infections, Mycobacterial infections, Fungal infections, Viral infections, Tuberculosis, Progressive multifocal leukoencephalopathy (PML), Herpes Zoster, Symptom Exacerbation, Fever, Respiratory distress, Hypotension, Disseminated intravascular coagulation (DIC), Multi-organ failure, Non-Melanoma Skin Cancer, Basal cell carcinoma, Squamous cell carcinoma, Merkel cell carcinoma"
207,AKYNZEO,adverse reactions,"headache, asthenia, dyspepsia, fatigue, constipation, erythema, transaminases elevation, total bilirubin elevation"
208,AKYNZEO,warnings and precautions,"Hypersensitivity reactions, anaphylaxis, Serotonin syndrome, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, death"
209,VIEKIRA,adverse reactions,"ALT elevations, fatigue, nausea, pruritus, skin reactions, insomnia, asthenia, serious adverse event (SAE), rash, erythema, eczema, rash maculo-papular, rash macular, dermatitis, rash papular, skin exfoliation, rash pruritic, rash erythematous, rash generalized, dermatitis allergic, dermatitis contact, exfoliative rash, photosensitivity reaction, psoriasis, skin reaction, ulcer, urticaria, dyspnea, serum bilirubin elevations, anemia, decreased hemoglobin, headache, cough, irritability, ocular icterus, jaundice, hyperbilirubinemia, muscle spasms, hypersensitivity reactions, angioedema"
210,VIEKIRA,warnings and precautions,"ALT elevations, fatigue, weakness, lack of appetite, nausea and vomiting, jaundice, discolored feces, liver inflammation, increased conjugated bilirubin, increased alkaline phosphatase, increased INR, loss of therapeutic effect, development of resistance, clinically significant adverse reactions, HIV-1 protease inhibitor resistance-associated substitutions"
211,PERJETA,adverse reactions,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, Diarrhea, Alopecia, Neutropenia, Nausea, Fatigue, Rash, Peripheral Neuropathy, Vomiting, Thrombocytopenia, Anemia, Asthenia, Edema Peripheral, Mucosal Inflammation, Pyrexia, Nail Disorder, Pruritus, Dry Skin, Constipation, Stomatitis, Febrile Neutropenia, Leukopenia, Headache, Dysgeusia, Dizziness, Myalgia, Arthralgia, Upper Respiratory Tract Infection, Nasopharyngitis, Dyspnea, Decreased Appetite, Lacrimation Increased, Insomnia, Paronychia, Pleural Effusion, Cardiac Disorders, Immune System Disorders, Peripheral Sensory Neuropathy, Cough, Epistaxis, Oropharyngeal Pain, Palmar-Plantar Erythrodysaesthesia Syndrome, Dyspepsia, ALT Increased, Hypokalemia, Death"
212,PERJETA,boxed warnings,"left ventricular dysfunction, CHF, decreased LVEF, subclinical cardiac failure, clinical cardiac failure, embryo-fetal death, birth defects, oligohydramnios, delayed renal development, death"
213,PERJETA,warnings and precautions,"Left Ventricular Dysfunction, LVEF decline, Symptomatic left ventricular systolic dysfunction, congestive heart failure, Embryo-fetal toxicity, Fetal harm, oligohydramnios, delayed fetal kidney development, embryo-fetal death, Infusion-Related Reactions, Hypersensitivity Reactions, Anaphylaxis, pyrexia, chills, fatigue, headache, asthenia, hypersensitivity, vomiting, dysgeusia, myalgia, severe hypersensitivity, death"
214,KEYTRUDA,adverse reactions,"immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, renal failure, immune-mediated nephritis, other immune-mediated adverse reactions, infusion-related reactions, fatigue, cough, nausea, pruritus, rash, decreased appetite, constipation, arthralgia, diarrhea, pain, serious adverse reactions, dyspnea, pneumonia, cellulitis, peripheral edema, chills, pyrexia, vomiting, abdominal pain, vitiligo, decreased appetite, pain in extremity, myalgia, back pain, headache, dizziness, anemia, insomnia, upper respiratory tract infection, sepsis, hyperglycemia, hyponatremia, hypoalbuminemia, hypertriglyceridemia, increased aspartate aminotransferase, hypocalcemia"
215,KEYTRUDA,warnings and precautions,"pneumonitis, immune-mediated pneumonitis, colitis, immune-mediated colitis, hepatitis, immune-mediated hepatitis, hypophysitis, thyroid disorders, hyperthyroidism, hypothyroidism, Type 1 diabetes mellitus, diabetic ketoacidosis, nephritis, immune-mediated nephritis, renal failure, interstitial nephritis, infusion-related reactions, embryofetal toxicity, exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures, severe dermatitis, bullous pemphigoid, myasthenic syndrome, optic neuritis, rhabdomyolysis, rigors, chills, wheezing, pruritis, flushing, rash, hypotension, hypoxemia, fever, death"
216,MYALEPT,adverse reactions,"headache, hypoglycemia, decreased weight, abdominal pain, arthralgia, dizziness, ear infection, fatigue, nausea, ovarian cyst, upper respiratory tract infection, anemia, back pain, diarrhea, paresthesia, proteinuria, pyrexia, injection-site erythema, urticaria, pancreatitis, severe infections, worsening of metabolic control, increases in HbA1c, increases in triglycerides"
217,MYALEPT,boxed warnings,"anti-metreleptin antibodies with neutralizing activity, inhibition of endogenous leptin action, loss of MYALEPT efficacy, severe infection, worsening metabolic control, T-cell lymphoma, significant hematologic abnormalities"
218,MYALEPT,warnings and precautions,"anti-metreleptin antibodies with neutralizing activity, loss of MYALEPT efficacy, severe infections, T-cell lymphoma, hematologic abnormalities, acquired generalized lipodystrophy, hypoglycemia, dose adjustment, insulin secretagogue therapy, autoimmune disorder progression, hypersensitivity reactions, anaphylaxis, urticaria, generalized rash, Benzyl Alcohol Toxicity, excessive weight gain, glucose intolerance, diabetes mellitus, severe bone marrow abnormalities, leukopenia, neutropenia, lymphadenopathy, autoimmune hepatitis, membranoproliferative glomerulonephritis, massive proteinuria, renal failure, death"
219,TRADJENTA,adverse reactions,"nasopharyngitis, hypoglycemia, diarrhea, cough, urinary tract infection, hypertriglyceridemia, hyperlipidemia, weight increased, constipation, back pain, arthralgia, upper respiratory tract infection, headache, pain in extremity, hypersensitivity, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity, myalgia, pancreatitis, severe hypoglycemia, acute pancreatitis, anaphylaxis, exfoliative skin conditions, severe and disabling arthralgia, rash, mouth ulceration, stomatitis, death"
220,TRADJENTA,warnings and precautions,"acute pancreatitis, fatal pancreatitis, hypoglycemia, serious hypersensitivity reactions, anaphylaxis, angioedema, exfoliative skin conditions, severe and disabling arthralgia, death"
221,BRINTELLIX,adverse reactions,"Hypersensitivity, Clinical Worsening, Suicide Risk, Serotonin Syndrome, Abnormal Bleeding, Activation of Mania/Hypomania, Hyponatremia, Nausea, Constipation, Vomiting, Diarrhea, Dry mouth, Flatulence, Dizziness, Abnormal dreams, Pruritus, Sexual Dysfunction, Discontinuation symptoms, Headache, Muscle tension, Mood swings, Sudden outbursts of anger, Runny nose, Laboratory Tests abnormalities, Weight changes, Vital Signs changes, Ear and labyrinth disorders, Vertigo, Dyspepsia, Dysgeusia, Flushing"
222,BRINTELLIX,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening, emergence of suicidal thoughts, emergence of suicidal behaviors"
223,BRINTELLIX,warnings and precautions,"Serotonin Syndrome, abnormal bleeding, Activation of Mania/Hypomania, Angle Closure Glaucoma, Hyponatremia, Clinical Worsening, Suicide Risk, suicidal ideation, suicidality, unusual changes in behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, mental status changes, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death"
224,AUBAGIO,adverse reactions,"Hepatotoxicity, Bone Marrow Effects, Immunosuppression Potential, Infections, Peripheral Neuropathy, Skin Reactions, Increased Blood Pressure, Respiratory Effects, headache, diarrhea, nausea, alopecia, increase in ALT, Paresthesia, Arthralgia, Neutropenia, Hypertension, Cardiovascular deaths, death, Acute Renal Failure, Hypophosphatemia"
225,AUBAGIO,boxed warnings,"hepatotoxicity, severe liver injury, fatal liver failure, death, major birth defects, elevated serum transaminases, teratogenicity"
226,AUBAGIO,warnings and precautions,"decreased WBC, signs and symptoms of infection, serious infection, peripheral neuropathy, Stevens-Johnson syndrome, toxic epidermal necrolysis, increased blood pressure, hepatotoxicity, fatal liver failure, liver dysfunction, elevated serum transaminases, ALT greater than three times the ULN, jaundice, serum transaminase increase, hepatic dysfunction, nausea, vomiting, abdominal pain, fatigue, anorexia, dark urine, teratogenic effects, fetal death, decrease in white blood cell count, neutrophils decrease, lymphocytes decrease, platelet count decrease, pancytopenia, agranulocytosis, thrombocytopenia, serious infections, klebsiella pneumonia sepsis, Pneumocystis jiroveci pneumonia, aspergillosis, cytomegalovirus hepatitis reactivation, tuberculosis, lymphoproliferative disorders, malignancy, polyneuropathy, mononeuropathy, carpal tunnel syndrome, hypertension, interstitial lung disease, cough, dyspnea, fever, hematologic toxicity, death"
227,POMALYST,adverse reactions,"Fetal Risk, Venous and Arterial Thromboembolism, Hematologic Toxicity, Hepatotoxicity, Hypersensitivity Reactions, Dizziness, Confusional State, Neuropathy, Second Primary Malignancies, Tumor Lysis Syndrome, Fatigue, Asthenia, Neutropenia, Anemia, Constipation, Nausea, Diarrhea, Dyspnea, Upper-respiratory Tract Infections, Back Pain, Pyrexia, Leukopenia, Febrile Neutropenia, Lymphopenia, Edema Peripheral, Chills, Vomiting, Musculoskeletal Chest Pain, Muscle Spasms, Arthralgia, Muscular Weakness, Bone Pain, Musculoskeletal Pain, Pain in Extremity, Pneumonia, Urinary Tract Infection, Sepsis, Decreased Appetite, Hypercalcemia, Hypokalemia, Hyperglycemia, Hyponatremia, Dehydration, Hypocalcemia, Cough, Epistaxis, Productive Cough, Oropharyngeal Pain, Peripheral Neuropathy, Headache, Tremor, Rash, Pruritus, Dry Skin, Hyperhidrosis, Night Sweats, Blood Creatinine Increased, Weight Decreased, Weight Increased, Anxiety, Insomnia, Renal Failure, Neutrophil Count Decreased, Platelet Count Decreased, White Blood Cell Count Decreased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Lymphocyte Count Decreased, Femur Fracture, Pelvic Pain, Myocardial Infarction, Atrial Fibrillation, Angina Pectoris, Cardiac Failure Congestive, Vertigo, Abdominal Pain, General Physical Health Deterioration, Non-cardiac Chest Pain, Multi-organ Failure, Hyperbilirubinemia, Pneumocystis Jiroveci Pneumonia, Respiratory Syncytial Virus Infection, Neutropenic Sepsis, Bacteremia, Pneumonia Respiratory Syncytial Viral, Cellulitis, Urosepsis, Septic Shock, Clostridium Difficile Colitis, Pneumonia Streptococcal, Lobar Pneumonia, Viral Infection, Lung Infection, Hemoglobin Decreased, Fall, Compression Fracture, Spinal Compression Fracture, Hyperkalemia, Failure to Thrive, Depressed Level of Consciousness, Syncope, Mental Status Change, Urinary Retention, Interstitial Lung Disease, Pulmonary Embolism, Respiratory Failure, Bronchospasm, Hypotension, Pancytopenia, Allergic Reactions, Angioedema, Urticaria, Elevated Liver Enzymes, Hepatic Failure, Death"
228,POMALYST,boxed warnings,"Embryo-Fetal Toxicity, Venous Thromboembolism, Arterial Thromboembolism, Severe Birth Defects, Embryo-Fetal Death, Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction, Stroke, Death"
229,POMALYST,warnings and precautions,"neutropenia, hematologic toxicities, Grade 3/4 adverse event, hepatotoxicity, hepatic failure, fatalities, death, liver function tests, hypersensitivity reactions, angioedema, severe dermatologic reactions, skin exfoliation, bullae, Tumor Lysis Syndrome (TLS), embryo-fetal death, venous thromboembolic events, deep venous thrombosis, pulmonary embolism, arterial thromboembolic events, myocardial infarction, stroke, anemia, thrombocytopenia, febrile neutropenia, elevated levels of alanine aminotransferase, elevated bilirubin levels, dizziness, confusional state, neuropathy, peripheral neuropathy, acute myelogenous leukemia, second primary malignancies"
230,SURFAXIN,adverse reactions,"endotracheal tube reflux, pallor, endotracheal tube obstruction, need for dose interruption, oxygen desaturation, bradycardia, apnea, intraventricular hemorrhage, periventricular leukomalacia, acquired sepsis, patent ductus arteriosus, retinopathy of prematurity, necrotizing enterocolitis, pulmonary air leak, pulmonary interstitial emphysema, pneumothorax, pulmonary hemorrhage, anemia, jaundice, metabolic acidosis, hyperglycemia, pneumonia, hyponatremia, hypotension, respiratory acidosis, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, decreased oxygen saturation, pneumothorax (duplicate, already listed), hypotension (duplicate, already listed), pulmonary embolism, death"
231,SURFAXIN,warnings and precautions,"acute changes in lung compliance, bradycardia, oxygen desaturation, reflux of SURFAXIN into the endotracheal tube, airway obstruction, endotracheal tube obstruction, death, multi-organ failure, sepsis, anoxic encephalopathy, renal failure, hypoxia, pneumothorax, hypotension, pulmonary embolism"
232,ARZERRA,adverse reactions,"Infusion reactions, Hepatitis B Virus Reactivation, Hepatitis B Virus Infection, Progressive Multifocal Leukoencephalopathy, Tumor Lysis Syndrome, Cytopenias, neutropenia, pneumonia, pyrexia, cough, diarrhea, anemia, fatigue, dyspnea, rash, nausea, bronchitis, upper respiratory tract infections, infections, sepsis, asthenia, headache, leukopenia, herpes simplex, lower respiratory tract infection, arthralgia, upper abdominal pain, pruritus, urticaria, agranulocytosis, edema peripheral, back pain, chills, nasopharyngitis, sepsis, urticaria, insomnia, herpes zoster, hyperhidrosis, hypertension, hypotension, muscle spasms, sinusitis, tachycardia, cardiac arrest, Stevens-Johnson syndrome, porphyria cutanea tarda, death"
233,ARZERRA,boxed warnings,"Hepatitis B Virus Reactivation, fulminant hepatitis, hepatic failure, death, Progressive Multifocal Leukoencephalopathy (PML)"
234,ARZERRA,warnings and precautions,"infusion reactions, bronchospasm, dyspnea, laryngeal edema, pulmonary edema, flushing, hypertension, hypotension, syncope, cardiac events, myocardial ischemia/infarction, acute coronary syndrome, arrhythmia, bradycardia, back pain, abdominal pain, pyrexia, rash, urticaria, angioedema, cytokine release syndrome, anaphylactoid reactions, anaphylactic reactions, tumor lysis syndrome (TLS), neutropenia, anemia, thrombocytopenia, late-onset neutropenia, prolonged neutropenia, hepatitis B virus reactivation, fulminant hepatitis, hepatic failure, death, hepatitis, hepatitis B infection, progressive multifocal leukoencephalopathy (PML), pancytopenia, agranulocytosis, neutropenic sepsis, immunizations"
235,ESBRIET,adverse reactions,"Liver Enzyme Elevations, Photosensitivity Reaction, Rash, Gastrointestinal Disorders, Nausea, Abdominal Pain, Upper Respiratory Tract Infection, Diarrhea, Fatigue, Headache, Dyspepsia, Dizziness, Vomiting, Anorexia, Gastro-esophageal Reflux Disease, Sinusitis, Insomnia, Weight Decreased, Arthralgia, Decreased Appetite, Pruritus, Asthenia, Dysgeusia, Non-cardiac Chest Pain, Agranulocytosis, Angioedema, Bilirubin Increased, ALT Increased, AST Increased"
236,ESBRIET,warnings and precautions,"Elevated liver enzymes, ALT elevations, AST elevations, bilirubin elevations, photosensitivity, rash, gastrointestinal disorders, nausea, vomiting, diarrhea, dyspepsia, gastro-esophageal reflux disease, abdominal pain, photosensitivity reactions, severe liver injury, liver transplant, death due to liver failure."
